WO2016158584A1 - Dilation catheter and method for manufacturing dilation catheter - Google Patents

Dilation catheter and method for manufacturing dilation catheter Download PDF

Info

Publication number
WO2016158584A1
WO2016158584A1 PCT/JP2016/059053 JP2016059053W WO2016158584A1 WO 2016158584 A1 WO2016158584 A1 WO 2016158584A1 JP 2016059053 W JP2016059053 W JP 2016059053W WO 2016158584 A1 WO2016158584 A1 WO 2016158584A1
Authority
WO
WIPO (PCT)
Prior art keywords
expansion
expansion body
shaft
dilatation catheter
slope
Prior art date
Application number
PCT/JP2016/059053
Other languages
French (fr)
Japanese (ja)
Inventor
賢一 雲山
雅貴 小野
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2017509836A priority Critical patent/JPWO2016158584A1/en
Publication of WO2016158584A1 publication Critical patent/WO2016158584A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters

Definitions

  • the present invention relates to a dilatation catheter that is a medical device and a method for producing the dilatation catheter.
  • catheter devices that are used to expand a lesion (stenosis) formed in a living body lumen, place a stent in the lesion, and the like are widely known (for example, the following patent documents) 1 and 2).
  • the balloon (expansion portion) provided in the catheter device as described above is required to satisfy both the passage of the lesion and the expandability when the lesion is expanded. For example, if the lesion is calcified and the symptom has progressed to a state close to complete obstruction, in order to pass the balloon through the lesion, reduce the diameter of the balloon as much as possible. While it is required to have a high passability, after passing through the lesion, it must have sufficient expandability to allow the calcified lesion to be expanded. It is done.
  • a method of reducing the thickness of the balloon is generally adopted as a measure for improving the passage of the balloon.
  • the balloon's scratch resistance rubbing strength
  • the expansion function of the balloon may be lowered when passing through a calcified lesion or the like.
  • the passage is improved by reducing the thickness of the balloon, even if the balloon can pass through the lesion, the expansion force acting on the lesion can be reduced.
  • the balloon thickness is increased in order to suppress a decrease in scratch resistance, naturally, the passage property will decrease, and if the balloon is formed of a flexible material, the balloon expandability will decrease. It will be. For this reason, it becomes difficult to achieve the initial purpose of providing a balloon catheter having passability and expandability that can be used for treatment of a calcified lesion.
  • the present invention has been made in view of the above problems, and provides a dilatation catheter including an dilatation portion that is improved in scratch resistance as well as passability and expansibility, and a method for manufacturing the dilatation catheter. For the purpose.
  • the dilatation catheter according to the present invention is a long shaft having flexibility that can be inserted into a living body lumen, and is fixed to a distal end portion of the shaft, and is used for supply and discharge of a pressurized medium via the shaft.
  • an expansion section composed of a first expansion body and a second expansion body configured to be capable of expansion deformation and contraction deformation, and the second expansion body is disposed so as to cover an outer surface of the first expansion body.
  • the first expansion body is made of a material having higher pressure resistance than the second expansion body, and the pressurizing medium.
  • the slope of the compliance curve indicating the continuous change in the outer diameter of the first expansion body per unit increase amount of the internal pressure of the expansion portion accompanying the supply of the continuation of the outer diameter when the second expansion body expands
  • the slope of the compliance curve Made is larger than a dilatation catheter.
  • the dilatation portion has improved scratch resistance due to the flexibility of the second dilation body covering the first dilation body, and the extensibility due to the pressure resistance of the first dilation body. Will be improved. Furthermore, since the slope of the compliance curve of the first expansion body is formed larger than the slope of the compliance curve of the second expansion body, the amount of expansion deformation of the first expansion body when the internal pressure of the expansion portion increases is It restrict
  • (A) is a figure which simplifies and shows the whole structure of an dilatation catheter
  • (B) is an expanded sectional view which shows the front end side of an dilatation catheter. It is a figure for demonstrating the structure of the expansion part with which the dilatation catheter which concerns on embodiment is equipped, Comprising: (A) is a fragmentary sectional view which expands and shows the expansion part in the contracted state, (B) is the expanded state It is a fragmentary sectional view which expands and shows the expansion part in FIG. It is a fragmentary sectional view which expands and shows 3A part shown to FIG. 2 (A).
  • FIG. 9 is a diagram showing a modification of the second expansion body, where (A) is a perspective view showing a part of the second expansion body in an enlarged manner, and (B) is a line 5A-5A shown in FIG. 5 (A). It is an axial orthogonal cross section of the 2nd expansion body in alignment with.
  • FIG. 1 is a diagram illustrating an overall configuration of an dilatation catheter according to the embodiment
  • FIGS. 2 and 3 are diagrams for explaining dilation portions (first dilation body and second dilation body) included in the dilatation catheter
  • FIG. It is a figure which shows the relationship between the change of the outer diameter of an expansion part, a 1st expansion body, and a 2nd expansion body, and the change of the internal pressure of an expansion part.
  • the dilatation catheter 100 has a long shaft 120 inserted through a living organ, and an dilation portion 200 disposed on the distal end side of the shaft 120. It is configured as a catheter device for expanding and treating the lesion by expanding the lesion at the lesion (stenosis). However, the dilatation catheter 100 can also be configured as a stent placement catheter device that is used to place a balloon-expandable stent (BX-type stent) in the lesion after the lesion is expanded, for example. .
  • BX-type stent balloon-expandable stent
  • the dilatation catheter 100 is configured as a PTCA dilatation catheter used to push and spread a lesion formed in the coronary artery.
  • a PTCA dilatation catheter used to push and spread a lesion formed in the coronary artery.
  • other blood vessels, bile ducts, trachea, esophagus can be configured to be used for the purpose of treatment and improvement of a lesion (stenosis) formed in a living organ such as the digestive tract, urethra, ear-nose lumen, and other organs.
  • the dilatation catheter 100 is fixed to a long shaft 120 having flexibility that can be inserted into a living body lumen, and a distal end portion of the shaft 120.
  • an expansion portion 200 including a first expansion body 210 and a second expansion body 220 and a hub 150 disposed on the base end side of the shaft 120 are provided.
  • the side on which the dilation portion 200 is provided is referred to as the distal end side
  • the side on which the hub 150 is provided is referred to as the proximal end side
  • the extending direction of the shaft 120 is referred to as the axial direction.
  • the dilatation catheter 100 is a so-called rapid exchange type in which an opening 135 through which the guide wire 180 is led out is provided near the distal end side of the shaft 120.
  • the dilatation catheter 100 can also be configured as a so-called over-the-wire type catheter device in which the guide wire lumen 131 extends from the distal end of the shaft 120 to the proximal end.
  • the shaft 120 has a pressurized medium between the inner tube (inner tube shaft) 130 in which the guide wire lumen 131 into which the guide wire 180 is inserted and the inner tube 130.
  • An outer tube (outer tube shaft) 140 that forms a flowable pressurized medium lumen 141 is formed.
  • the shaft 120 has a double tube structure in which the inner tube 130 is inserted into the outer tube 140 and the inner tube 130 and the outer tube 140 are concentrically positioned.
  • a tip tip 240 made of a member different from the inner tube 130 is fixed to the tip of the inner tube 130.
  • the guide wire lumen 131 extends into the shaft 120 so as to communicate with two openings, a distal end opening 243 formed at the distal end of the distal end tip 240 and a proximal end opening 135 formed at the proximal end of the inner tube 130.
  • the distal tip 240 attached to the distal end of the inner tube 130 has a function of preventing the living organ from being damaged when the distal end of the dilatation catheter 100 comes into contact with the living organ (such as the inner wall of the blood vessel).
  • the distal tip 240 can be constituted by a tubular member that is more flexible than the inner tube 130, for example. Further, the distal tip 240 can be formed in a tapered shape in which the outer diameter gradually decreases toward the distal end side as illustrated in consideration of the insertion property into the biological lumen and the mobility in the biological lumen. It is. However, the installation of the tip tip 240 can be omitted as appropriate.
  • the inner tube 130 is configured by a hollow tube material whose proximal end is curved radially outward. Near the distal end of the inner tube 130 and the proximal end of the distal tip 240, the distal end portion 211 of the first expansion body 210 provided in the expansion portion 200 is joined in a liquid-tight and air-tight manner by a known method such as welding (FIG. 2 (B)).
  • the guide wire 180 has a guide wire lumen 131 with the distal end opening 243 of the distal end tip 240 provided at the distal end of the inner tube 130 and the proximal end opening 135 provided at the proximal end of the inner tube 130 as inlets or outlets, respectively. Is inserted.
  • Examples of the material constituting the inner tube 130 include polyolefins such as polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, thermoplastic resins such as soft polyvinyl chloride, silicone rubber, latex rubber, etc. These various rubbers, various elastomers such as polyurethane elastomer, polyamide elastomer and polyester elastomer, and crystalline plastics such as polyamide, crystalline polyethylene and crystalline polypropylene can be used. In these materials, for example, an antithrombotic substance such as heparin, prostaglandin, urokinase, arginine derivative or the like can be blended to obtain a material having antithrombotic properties.
  • polyolefins such as polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, thermoplastic resins such as soft polyvinyl chloride, silicone rubber,
  • the outer tube 140 is formed of a hollow tube material extending from the vicinity of the base end portion of the expansion portion 200 (the base end portion 213 of the first expansion body 210 and the base end portion 213 of the second expansion body 220) to the hub 150. ing. In the vicinity of the distal end of the outer tube 140, a base end portion 213 of the first expansion body 210 provided in the expansion portion 200 is joined in a liquid-tight and air-tight manner by a known method such as welding (see FIG. 2B). .
  • the same material as that of the inner tube 130 can be used. It is also possible to coat a substance having antithrombogenicity on a portion of the outer tube 140 that comes into contact with blood (for example, the outer surface of the outer tube 140).
  • the hub 150 includes a connecting portion 151 that can be connected in a liquid-tight and air-tight manner to a supply device (not shown) such as an indeflator for supplying a pressurized medium.
  • a supply device such as an indeflator for supplying a pressurized medium.
  • the connecting portion 151 of the hub 150 can be configured by, for example, a known luer taper configured such that a fluid tube or the like can be connected / separated.
  • the pressurized medium (for example, physiological saline, contrast medium, etc.) used for the expansion of the expansion part 200 can be caused to flow into the shaft 120 via the connection part 151 of the hub 150.
  • the pressurized medium is supplied to the internal space 207 of the expansion unit 200 via the pressurized medium lumen 141.
  • the internal space 207 of the expansion part 200 is a space part that is defined between the inner surface of the first expansion body 210 provided in the expansion part 200 and the outer surface of the inner tube 130 (see FIG. 2B). ).
  • the expansion part 200 includes a first expansion body 210 disposed inside the expansion part 200 (near the inner tube 130), and an outer surface of the first expansion body 210. And the second expansion body 220 arranged so as to cover. That is, the expansion part 200 has a two-layer structure including a first expansion body 210 forming an inner layer and a second expansion body 220 forming an outer layer.
  • Each of the first expansion body 210 and the second expansion body 220 is configured to be capable of expansion deformation and contraction deformation as the pressurized medium flows into and out of the internal space 207 of the expansion portion 200.
  • the expanded portion 200 is a portion having a function of expanding the lesioned portion or the like as a whole by combining the first expanded body 210 and the second expanded body 220, that is, a portion having the same function as a balloon in a conventionally known balloon catheter. It is configured as.
  • the first dilation body 210 and the second dilation body 220 have different functions by providing the first dilation body 210 and the second dilation body 220 with different physical properties. I have it.
  • the first expansion body 210 mainly plays a role of increasing the expansion force applied when the expansion section 200 spreads the lesioned area
  • the second expansion body 220 mainly functions as the expansion section 200. It plays the role of improving the scratch resistance and adjusting the outer diameter (expansion deformation amount) of the expanded portion 200 during expansion.
  • the first expansion body 210 is made of a material having a higher pressure resistance than the second expansion body 220 (a material having a high pressure property).
  • a constituent material of the first expansion body 210 for example, polyamide, PET, or the like can be used.
  • the constituent material of the first expansion body 210 is preferably polyamide.
  • polystyrene resin examples include polytetramethylene adipamide (nylon 46), polycaprolactam (nylon 6), polyhexamethylene adipamide (nylon 66), polyhexamethylene sebacamide (nylon 610), polyhexamethylene Homopolymers such as dodecanamide (nylon 612), polyundecanolactam (nylon 11), polydodecanolactam (nylon 12), caprolactam / lauryl lactam copolymer (nylon 6/12), caprolactam / aminoundecanoic acid co Copolymers (nylon 6/11), caprolactam / ⁇ -aminononanoic acid copolymer (nylon 6/9), caprolactam / hexamethylene diammonium adipate copolymer (nylon 6/66), adipic acid and Meta-xylene Copolymers of, or hexamethylene diamine and m, and aromatic polyamides such as
  • polyamide elastomer which is a block copolymer having nylon 6, nylon 66, nylon 11, nylon 12 or the like as a hard segment and polyalkylene glycol, polyether or aliphatic polyester as a soft segment. is there.
  • the said polyamide may be used individually by 1 type, and may use 2 or more types together.
  • the second expansion body 220 is made of a material that is more flexible than the first expansion body 210.
  • a polyester elastomer, a polyamide elastomer, a polyolefin (for example, polyethylene, polypropylene), a polymer material such as polyvinyl chloride, a fluororesin, silicon, urethane, or a mixture thereof, or the above Two or more polymer materials can be used.
  • elastomer materials such as a polyester elastomer and a polyamide elastomer, are preferable, and a polyamide elastomer is especially preferable.
  • the first dilation body 210 is formed with a larger slope of the compliance curve than the second dilation body 220.
  • a compliance curve and its inclination will be described.
  • FIG. 4 the change of the internal pressure of the expansion part 200, the change of the outer diameter of the first expansion body 210 (solid line A in the figure), the change of the outer diameter of the second expansion body 220 (dashed line B in the figure), And the relationship with the change (two-dot chain line C in a figure) of the outer diameter of the expansion part 200 is shown in illustration.
  • Curve A shows a continuous change in the outer diameter of the first expansion body 210 per unit increase amount of the internal pressure (expansion deformation) when the pressurized medium is supplied to the expansion section 200 and the internal pressure of the expansion section 200 increases.
  • the compliance curve (compliance curve) showing the amount) is shown.
  • Curve B shows a continuous change in the outer diameter of the second expansion body 220 per unit increase amount of the internal pressure when the pressurized medium is supplied to the expansion unit 200 and the internal pressure of the expansion unit 200 increases.
  • the compliance curve shown is shown.
  • the slope of the compliance curve is the ratio of the amount of expansion deformation when the same pressure is applied. The larger the slope of the compliance curve, the lower the slope of the compliance curve. This also means that the amount of expansion deformation increases in the state where the same pressure is applied.
  • the compliance value indicating the physical properties of each expansion body 210, 220 is the pressure (internal pressure) applied to the expansion portion 200 when the absolute value of the outer diameter of each expansion body 210, 220 is expanded to the outer diameter. The value obtained by dividing by the absolute value of.
  • the slope of the compliance curve A of the first expansion body 210 is the compliance curve of the second expansion body 210 after the internal pressure of the expansion section 200 reaches a predetermined value Ps. It is set to be larger than the slope of B.
  • the inclination of the compliance curve A of the first expansion body 210 and the inclination of the compliance curve B of the second expansion body 210 of the second expansion body 220 are substantially the same until the internal pressure of the expansion portion 200 reaches a predetermined value Ps. It is set to become.
  • predetermined value Ps can be set to a pressure at a timing when the application of the expansion pressure from the expansion unit 200 to the lesioned part is started in performing various procedures using the expansion catheter 100, for example. For example, it is possible to set 1 to 20 atm.
  • each of the expansion bodies 210 and 220 is made of a material having different physical properties, and defines the magnitude relationship between the slopes of the compliance curves of the expansion bodies 210 and 220. 200 has the following performance.
  • the second expansion body 220 having higher flexibility than the first expansion body 210 is in the radial direction.
  • the entire extended portion 200 is in close contact with the inner tube 130. For this reason, the outer diameter of the expanded portion 200 at the time of contraction is reduced, and the permeability to the lesioned portion is improved.
  • the second expansion body 220 forming the outer layer functions as a flexible layer that protects the first expansion body 210, the scratch resistance of the expansion portion 200 is improved. Therefore, even when the lesion is calcified and the symptom has progressed to a state close to complete occlusion, the entire expanded portion 200 can be suitably protected when passing through the lesion.
  • the first expansion body 210 and the second expansion body 220 expand according to the compliance curve shown in FIG. Specifically, until the internal pressure of the expansion unit 200 reaches a predetermined pressure Ps, the expansion bodies 210 and 220 expand so that the slopes of the compliance curves A and B become substantially the same, After the internal pressure reaches the predetermined pressure Ps, the expansion bodies 210 and 220 are arranged such that the slope of the compliance curve A of the first expansion body 210 is larger than the slope of the compliance curve B of the second expansion body 220. Expands.
  • the expansion deformation of the first expansion body 210 is limited according to the outer diameter of the second expansion body 220 that covers the outer surface of the first expansion body 210.
  • the in the present embodiment the first expansion body 210 and the second expansion body 220 are both expanded, and a tensile force (tension) is applied to the second expansion body 220 formed more flexibly than the first expansion body 210 to some extent. Then, the expansion of the second expansion body 220 reaches the limit, and the subsequent expansion deformation of the second expansion body 220 is suppressed. At this timing, the expansion deformation of the first expansion body 210 starts to be limited (see FIG. 2B).
  • the slope of the compliance curve C (two-dot chain line in the figure) indicating a continuous change in the outer diameter of the entire expanded portion 200 is the slope of the compliance curve A of the first expanded body 210 and that of the second expanded body 220. It is adjusted to an intermediate value between the slopes of the compliance curve B. That is, the outer diameter of the expansion part 200 changes so as to change at an intermediate value between the outer diameter of the first expansion body 210 and the outer diameter of the second expansion body 220. Therefore, when expanding the lesioned part, it is possible to prevent the entire expanded part 200 from expanding and deforming indefinitely as the internal pressure increases, and a desired expansion force can be applied to the lesioned part. .
  • the expansion bodies 210 and 220 expand so that the slopes of the compliance curves A and B become substantially the same.
  • the expansion deformation is not limited by the second expansion body 220. Therefore, before the start of applying the expansion force to the lesioned part, the entire expansion part 200 can be rapidly expanded and deformed.
  • the constituent material of the first expansion body 210 and the second expansion body It is possible to perform adjustment by adjusting the material of the constituent material 220, adjusting the expansion ratio (adjusting the molecular orientation in the material) when forming the tube-shaped material (parison) constituting each expansion body 210, 220, and the like. .
  • the thickness (film thickness) d1 of the first expansion body 210 before the expansion portion 200 is expanded and deformed (the expansion portion 200 is folded) is the second expansion body 220. It can be formed to be thinner than the thickness (film thickness) d2.
  • 3 is an enlarged cross-sectional view showing a portion surrounded by a broken line portion 3A shown in FIG.
  • the outer surface of the first expansion body 210 is covered with the second expansion body 220 having excellent scratch resistance. For this reason, even when the thickness d1 of the first expansion body 210 having a relatively large pressure resistance (relatively low scratch resistance) is formed thin, the first expansion is performed when the expansion portion 200 is passed through the lesion. The body 210 can be protected. Therefore, the thickness d1 of the first expansion body 210 can be formed thinner than that of the second expansion body 220.
  • the second expansion body 220 is to add scratch resistance to the expansion portion 200, that is, to prevent the occurrence of trauma due to a load applied from the outside of the expansion portion 200. Therefore, it is not necessary to set the wall thickness d2 excessively large. Therefore, in this embodiment, the thickness d3 of the expansion portion 200, which is the sum of the thickness d1 of the first expansion body 210 and the thickness d2 of the second expansion body 220, is the balloon of a conventionally known general balloon catheter. It is possible to design smaller than the above. Of course, even when the wall thickness d3 of the extended portion 200 is designed to be small, desired scratch resistance can be maintained.
  • the internal space 207 of the expansion part 200 does not communicate with the space formed between the outer surface of the first expansion body 210 and the inner surface of the second expansion body 220.
  • the expansion unit 200 according to the present invention allows the second expansion body 220 to expand due to the expansion of the first expansion body 210 even when a trauma or the like occurs due to a load applied from the outside of the expansion unit 200. Can be extended.
  • the wall thickness d1 of the first dilator 210 is:
  • the thickness d2 of the second expansion body 220 can be formed to be 2 to 9 ⁇ m, for example, and the total of the first expansion body 210 and the second expansion body 220 can be formed.
  • the wall thickness (thickness of the extended portion 200) d3 can be formed to 3 to 10 ⁇ m, for example.
  • the wall thickness d1 of the first expansion body 210 is preferably configured to be thinner than the wall thickness d2 of the second expansion body 220.
  • the thickness d1 of the first dilation body 210 can be formed, for example, to 1 to 28 ⁇ m, and the wall thickness d2 of the second dilation body 220. Can be formed to, for example, 2 to 29 ⁇ m, and the total thickness (thickness of the expanded portion 200) d3 of the first extension body 210 and the second extension body 220 is, for example, 3 to 30 ⁇ m. Can do.
  • the wall thickness d1 of the first expansion body 210 is preferably configured to be thinner than the wall thickness d2 of the second expansion body 220.
  • the dimensions of the thickness d1 of the first expansion body 210, the thickness d2 of the second expansion body 220, and the thickness d3 of the expansion section 200 are examples, and the thickness of each section is limited to these values. Absent.
  • the distal end portion 211 is fixed to the distal end portion of the inner tube 130 and the distal end tip 240, and the proximal end portion 213 is the outer tube 140. It is fixed to the tip of the.
  • a distal end side taper portion 211a is formed on the proximal end side of the distal end portion 211 so that the outer diameter increases toward the proximal end side.
  • the distal end side of the proximal end portion 213 is directed toward the distal end side.
  • a proximal side taper portion 213a that changes so as to increase the outer diameter is formed.
  • a straight portion 215 extending in a substantially linear shape is formed between the distal end side tapered portion 211a and the proximal end side tapered portion 213a.
  • the distal end portion 221 is fixed to the outer surface of the distal end portion 211 of the first expansion body 210, and the base end portion 223 is the first expansion end. It is fixed to the outer surface of the base end portion 213 of the one expansion body 210.
  • a distal end side taper portion 221a that changes so that the outer diameter increases toward the proximal end side is formed on the proximal end side of the distal end portion 221, and the distal end side of the proximal end portion 223 has a distal end side.
  • a proximal-side tapered portion 223a that changes so as to increase the outer diameter toward is formed.
  • a straight portion 225 extending substantially linearly is formed between the distal end side tapered portion 221a and the proximal end side tapered portion 223a.
  • the distal end surface of the first expansion body 210 and the distal end surface of the second expansion body 220 have a tapered shape that tapers toward the distal end side in order to improve the passage to the lesioned part. It is possible to form.
  • the shape of the tip surface of each expansion body 210, 220 is not limited to the tapered shape as shown in the figure.
  • the second expansion body 220 is not limited to the shape of FIG. 2B as long as it covers the outer surface of the first expansion body 210, and the distal end portion 221 is more distal than the distal end portion 211 of the first expansion body 210. It may be disposed on the side and fixed to the distal end portion of the inner tube 130 and the distal end tip 240. Further, the base end portion 223 of the second expansion body 220 may be disposed on the base end side with respect to the base end portion 213 of the first expansion body 210 and may be fixed to the outer tube 140.
  • a substantially cylindrical tube-shaped material (parison) constituting the first expansion body 210 and a substantially cylindrical tube-shaped material (parison) constituting the second expansion body 220 are prepared.
  • Each of these materials is the same as that used in the manufacture of a balloon provided in a general balloon catheter, for example, using a predetermined molding die (balloon molding die or the like) as the constituent material of each expansion body 210, 220. And can be obtained by molding.
  • the first expansion body 210 is fixed to the shaft 120, and the second expansion body 220 disposed so as to cover the outer surface of the first expansion body 210 is fixed to the first expansion body 210, thereby the shaft 120. It is possible to provide the extension part 200 in the.
  • the portion where the straight portion 215 of the first expansion body 210 and the straight portion 225 of the second expansion body 220 overlap in the axial direction is an effective expansion portion (pressurizing portion) that applies expansion force to the lesioned portion. ) 205 is configured.
  • the inner tube 130 included in the shaft 120 has a position X at which the central portion P1 of the expansion portion 200 (the central portion of the expansion effective portion 205) is projected in the axial direction of the shaft 120.
  • a line contrast marker 160 is provided.
  • the X-ray contrast marker 160 has both end portions 161 and 163 in the axial direction of the shaft 120 each having a tapered shape in which the outer diameter gradually decreases toward the distal end side and the proximal end side.
  • the X-ray contrast marker 160 when performing a procedure using the dilatation catheter 100, it becomes possible to easily confirm the central portion P1 of the dilation portion 200 on the X-ray image, so that the procedure can be performed quickly. It becomes possible to do.
  • the distal end portion 161 of the X-ray contrast marker 160 is formed in a tapered shape whose outer diameter gradually decreases toward the distal end side, and the proximal end portion 163 of the X-ray contrast marker 160 is outwardly directed toward the proximal end side. Since the diameter gradually decreases, the first expansion body 210 can be protected from rubbing between the first expansion body 210 and the X-ray contrast marker 160 when the expansion section 200 is passed through the lesion. It becomes possible.
  • the first dilator 210 may be made of a material having a relatively small scratch resistance and may be formed with a small thickness.
  • the first expansion body 210 when the expansion portion 200 contracts, the first expansion body 210 is in close contact with the inner tube 130 as the relatively flexible second expansion body 220 contracts. For this reason, when the expansion part 200 is passed through the lesioned part, the first expansion body 210 may be rubbed by being caught on both end parts 161 and 163 of the X-ray contrast marker 160. Therefore, by forming both end portions 161 and 163 of the X-ray contrast marker 160 in a smooth tapered shape, it is possible to protect against such rubbing. Furthermore, the passability of the X-ray contrast marker 160 to the lesioned part can be improved.
  • the X-ray contrast marker 160 is, for example, a ring-shaped member having X-ray contrast properties that is processed into a tapered shape by fitting and fixing the inner tube 130, or a ring-shaped member having X-ray contrast properties. It is possible to provide by combining and fixing the member and another member constituting the tapered portion into the inner tube 130 so as to be integrated.
  • a constituent material of the X-ray contrast marker 160 what was comprised with metals, such as platinum, gold
  • a hydrophilic coat layer (surface lubrication layer) is formed on the outer surface of the second extension body 220 provided in the extension portion 200. Since the hydrophilic coat layer is provided on the outer surface of the second expansion body 220, when the expansion section 200 is moved in the living body lumen or passed through the lesioned portion, the space between the second expansion body 220 and each section is determined. The frictional resistance is reduced. As described above, the second expansion body 220 is made of a relatively flexible material in order to improve the scratch resistance of the expansion portion 200, and the frictional resistance tends to increase accordingly. By forming a hydrophilic coat layer on the outer surface of the second expanded body 220, the frictional resistance to the lesioned part is reduced while maintaining the scratch resistance, and the passage to the lesioned part is further improved. Become.
  • the hydrophilic coat layer is formed by applying a solvent constituting the hydrophilic coat layer (a solvent containing a hydrophilic polymer) to the outer surface of the second extended body 220 and then applying hydrophilicity to the outer surface of the second extended body 220.
  • a solvent constituting the hydrophilic coat layer a solvent containing a hydrophilic polymer
  • It can be formed by crosslinking a polymer.
  • the solvent for example, DMF, chloroform, acetone, THF, dioxane, benzene and the like can be used. These may be used alone or in combination of two or more.
  • crosslinking it can carry out by heat processing and / or electron beam irradiation, for example.
  • the first expansion body 210 is prepared (first preparation step).
  • first preparation step for example, a tube-shaped material constituting the first expansion body 210 is purchased and prepared, or the tube-shaped material is molded using a molding die to obtain the first expansion body 210.
  • the second expansion body 220 is prepared (second preparation step).
  • the tube-shaped material constituting the second expansion body 220 is purchased and prepared, or the tube-shaped material is formed using a forming die.
  • a second expansion body 220 is obtained.
  • a 1st preparatory process and a 2nd preparatory process are random, and you may replace process order.
  • the first preparation process and the second preparation process are collectively referred to as a preparation process.
  • the shaft 120 can be prepared in advance in a state where the inner tube 130, the outer tube 140, and the hub 150 are assembled prior to performing the work of fixing the first expansion body 210.
  • the shaft assembly is a work product (intermediate product) in a state where the first expansion body 210 is fixed to the shaft 120 for convenience.
  • the first expansion body 210 can be fixed to the shaft 120 by a known method such as welding or fusion.
  • a hydrophilic polymer solvent is applied to the outer surface of the second expansion body 220 (application process). Thereafter, the second expansion body 220 is subjected to heat treatment and / or electron beam treatment to crosslink the hydrophilic polymer to form a hydrophilic coat layer (coat layer forming step).
  • coating process and a coating layer formation process before a shaft assembly formation process.
  • the second expansion body 220 is fixed to the shaft assembly so as to cover the first expansion body 210 fixed to the shaft 120.
  • the second expansion body 220 may be directly fixed to the shaft 120, or may be fixed to the first expansion body 210 as shown in FIG.
  • the second expansion body 220 can be fixed to the shaft assembly by a known method such as welding or fusion.
  • a hydrophilic coat layer is formed by applying a thermal load to a material having a relatively high pressure resistance such as the first expansion body 210 and having a thin wall thickness. Under the influence of heat, deformation such as thermosetting can easily occur in the material of the first expansion body 210 itself. For this reason, it becomes difficult to crosslink the hydrophilic polymer and firmly fix the hydrophilic coat layer to the outer surface of the first expansion body 210.
  • the outer surface of the second dilator 220 that is relatively less likely to be deformed than the first dilator 210 when a thermal load is applied.
  • the hydrophilic polymer is crosslinked by heat treatment or electron beam treatment.
  • the hydrophilic coat layer can be firmly fixed to the outer surface of the second expansion body 220.
  • the second expansion body 220 is subjected to a heat treatment or an electron beam process, so that the first expansion body 210 is thermally affected. Therefore, it is possible to prevent the first expansion body 210 from being undesirably deformed with the formation of the hydrophilic coat layer.
  • the dilation portion 200 has improved scratch resistance due to the flexibility of the second dilation body 220 that covers the first dilation body 210, and the first dilation body.
  • the expandability is improved by the pressure resistance of 210.
  • the slope of the compliance curve of the first expansion body 210 is larger than the slope of the compliance curve of the second expansion body 220, the expansion of the first expansion body 210 when the internal pressure of the expansion portion 200 increases.
  • the amount of deformation is limited according to the expansion diameter of the second expansion body 220. Therefore, even when the expanded portion 200 is configured to have a reduced diameter by reducing the thickness of the first expanded body 210 and the thickness of the second expanded body 220, the entire expanded portion 200 acts on the lesion. It is possible to increase the expansion force to a desired magnitude. Therefore, it is possible to provide the dilatation catheter 100 including the dilation portion 200 in which the scratch resistance is improved as well as the passability and the expansibility.
  • the expansion portion 200 is formed by forming the first expansion body 210 thin.
  • the overall thickness can be reduced, and the expanded portion 200 can be configured with a further reduced diameter.
  • the slope of the compliance curve of the first expansion body 210 is greater than the slope of the compliance curve of the second expansion body 210 after the internal pressure of the expansion section 200 reaches a predetermined value Ps as the pressurized medium is supplied. Since the inclination of the compliance curve of the second expansion body 220 is substantially the same until the internal pressure of the expansion portion 200 reaches the predetermined value Ps, the stage before the internal pressure of the expansion portion 200 reaches the predetermined pressure Ps. In, the expansion deformation of the first expansion body 210 is not limited by the second expansion body 220, and the entire expansion portion 200 can be rapidly expanded and deformed.
  • the shaft 120 (inner tube 130) has an X-ray contrast marker 160 that indicates a position at which the central portion P1 of the expansion part 200 is projected in the axial direction of the shaft 120.
  • the X-ray contrast marker 160 is Since both end portions 161 and 163 in the axial direction of 120 are formed in a tapered shape whose outer diameter gradually decreases toward the distal end side and the proximal end side, the first expansion is performed when the expanded portion 200 is passed through the lesioned portion. It becomes possible to suitably protect the first expansion body 210 from rubbing between the body 210 and the X-ray contrast marker 160.
  • the shaft 120 and an expansion portion 200 that can be expanded and contracted and fixed to the tip portion of the shaft 120 are provided.
  • the outer surface of the first expansion body 210 included in the expansion portion 200 is covered by the second expansion body 220. It is possible to provide a method for manufacturing the dilatation catheter 100 configured as described above. Specifically, a long shaft 120 having flexibility that can be inserted into a living body lumen, and fixed to the distal end portion of the shaft 120, and expanded as a pressurized medium is supplied and discharged through the shaft 120. And a second expansion body formed of a material more flexible than the first expansion body 210 and the first expansion body 210.
  • the first expansion body 210 includes a second expansion body. It is made of a material having higher pressure resistance than the body 220, and shows a continuous change in the outer diameter of the first expansion body 210 per unit increase amount of the internal pressure of the expansion section 200 accompanying supply of the pressurized medium. This is a method for manufacturing the dilatation catheter 100 in which the slope of the compliance curve is formed to be larger than the slope of the compliance curve indicating a continuous change in the outer diameter when the second dilator 220 is expanded.
  • the hydrophilic coat layer can be firmly fixed to the outer surface of the second extension body 220, and unnecessary deformation or the like is prevented from occurring in the first extension body 210 due to the formation of the hydrophilic coat layer. It is possible to provide a method of manufacturing the dilatation catheter 100 that can be used.
  • FIG. 5A is an enlarged perspective view showing a part of the second expanded body 320 according to the modified example
  • FIG. 5B is an axial orthogonal cross-sectional view of the second expanded body 320 according to the modified example (FIG. 5).
  • FIG. 5A is a cross-sectional view taken along line 5A-5A in FIG.
  • the second expansion body 320 disposed so as to cover the first expansion body 210 for example, as shown in this modification, a structure in which a plurality of uneven portions 325 are formed along the circumferential direction of the outer surface is used. Is possible. As described above, since the uneven portion 325 is formed on the outer surface, when the expanded portion 200 is expanded, a mechanical locking force acts on the lesion portion where the second expanded body 320 is calcified. Let me eat it. That is, since it becomes possible to add a scoring function to the expansion part 200, it becomes possible to enhance the expansion action (therapeutic effect) of the lesioned part. In addition, since the contact area between the outer surface of the second expansion body 320 and the lesioned portion when passing through the lesioned portion is reduced, it is possible to further improve the passage through the lesioned portion.
  • a tube-shaped material having a hexagonal axial cross section is used for the second expansion body 320.
  • the second expansion body 320 is formed with a lumen 323 into which the first expansion body 210 can be inserted as shown in the drawing in consideration of workability at the time of fixing to the first expansion body 210 and the like. It is possible to use.
  • the material of the second expansion body 320, the slope of the compliance curve, and the like can be configured in the same manner as in the first embodiment described above.
  • the above-described hydrophilic coat layer can be provided on the outer surface of the second expansion body 320.
  • the dilatation catheter and the manufacturing method thereof according to the present invention have been described through the embodiment and the modification.
  • the present invention is not limited to the configuration described in the embodiment and the modification, and the description of the claims It is possible to change appropriately based on the above.

Abstract

[Problem] To provide a dilation catheter including a dilating part with enhanced passage properties, dilatability, and abrasion resistance, and also provide a method for manufacturing said dilation catheter. [Solution] A dilation catheter 100 includes a dilating part 200 that is constituted from a first dilation body 210 and a second dilation body 220 disposed so as to cover the first dilation body. The second dilation body is constituted from a more flexible material than the first dilation body. The first dilation body is constituted from a material having higher pressure resistance than the second dilation body, and is formed such that the slope of the compliance curve thereof is greater than the slope of the compliance curve of the second dilation body.

Description

拡張カテーテル、および拡張カテーテルの製造方法Dilatation catheter and dilatation catheter manufacturing method
 本発明は、医療装置である拡張カテーテル、および拡張カテーテルの製造方法に関する。 The present invention relates to a dilatation catheter that is a medical device and a method for producing the dilatation catheter.
 医療分野において、生体管腔内に形成された病変部(狭窄部)の拡張や病変部へのステントの留置等を行う際に使用されるカテーテルデバイスが広く知られている(例えば、下記特許文献1、2を参照)。 2. Description of the Related Art In the medical field, catheter devices that are used to expand a lesion (stenosis) formed in a living body lumen, place a stent in the lesion, and the like are widely known (for example, the following patent documents) 1 and 2).
 上記のようなカテーテルデバイスに備えられるバルーン(拡張部)には、病変部の通過性と、病変部を押し広げる際の拡張性の両立が求められる。例えば、病変部が石灰化しており、症状が完全閉塞に近い状態まで進行しているような場合、病変部にバルーンを通過させるために、通過時においては、バルーンを可能な限り細径化して通過性を高めた状態にすることが求められる一方で、病変部を通過させた後においては、石灰化された病変部を押し広げることを可能にする十分な拡張性が備わっていることが求められる。 The balloon (expansion portion) provided in the catheter device as described above is required to satisfy both the passage of the lesion and the expandability when the lesion is expanded. For example, if the lesion is calcified and the symptom has progressed to a state close to complete obstruction, in order to pass the balloon through the lesion, reduce the diameter of the balloon as much as possible. While it is required to have a high passability, after passing through the lesion, it must have sufficient expandability to allow the calcified lesion to be expanded. It is done.
特開2012-20077号公報JP 2012-20077 A 特開2012-5705号公報JP 2012-5705 A
 通常、バルーンの通過性を向上させるための対策としてバルーンの肉厚を薄くする方法を採用するのが一般的である。ただし、バルーンの肉厚を薄くすると、バルーンの耐擦過性(擦れ強度)が低下するため、石灰化された病変部等を通過させる際にバルーンの拡張機能の低下を招く可能性がある。つまり、バルーンの肉厚を薄くすることにより通過性の向上を図ると、バルーンが病変部を通過できるようになったとしても、病変部に対して作用させる拡張力の低下が発生し得る。 Usually, a method of reducing the thickness of the balloon is generally adopted as a measure for improving the passage of the balloon. However, if the balloon wall thickness is reduced, the balloon's scratch resistance (rubbing strength) is lowered, so that the expansion function of the balloon may be lowered when passing through a calcified lesion or the like. In other words, when the passage is improved by reducing the thickness of the balloon, even if the balloon can pass through the lesion, the expansion force acting on the lesion can be reduced.
 例えば、耐擦過性の低下を抑えるために、バルーンの肉厚を厚くすると、当然、通過性の低下を招くことになり、またバルーンを柔軟な素材で形成すると、バルーンの拡張性の低下を招くことになる。このため、石灰化された病変部の治療に対応可能な通過性および拡張性を備えるバルーンカテーテルを提供するという当初の目的を達成し難くなってしまう。 For example, if the balloon thickness is increased in order to suppress a decrease in scratch resistance, naturally, the passage property will decrease, and if the balloon is formed of a flexible material, the balloon expandability will decrease. It will be. For this reason, it becomes difficult to achieve the initial purpose of providing a balloon catheter having passability and expandability that can be used for treatment of a calcified lesion.
 本発明は、上記のような問題に鑑みてなされたものであり、通過性および拡張性とともに耐擦過性の向上が図られた拡張部を備える拡張カテーテル、および当該拡張カテーテルの製造方法を提供することを目的とする。 The present invention has been made in view of the above problems, and provides a dilatation catheter including an dilatation portion that is improved in scratch resistance as well as passability and expansibility, and a method for manufacturing the dilatation catheter. For the purpose.
 本発明に係る拡張カテーテルは、生体管腔内に挿入可能な可撓性を備える長尺状のシャフトと、前記シャフトの先端部に固定され、前記シャフトを介した加圧媒体の供給および排出に伴い拡張変形および収縮変形可能に構成された第1拡張体および第2拡張体からなる拡張部と、を備え、前記第2拡張体は、前記第1拡張体の外表面を覆うように配置され、かつ、前記第1拡張体よりも柔軟な材料で構成されており、前記第1拡張体は、前記第2拡張体よりも耐圧性の高い材料で構成されており、かつ、前記加圧媒体の供給に伴う前記拡張部の内圧の単位増加量あたりにおける当該第1拡張体の外径の連続的な変化を示すコンプライアンス曲線の傾きが、前記第2拡張体が拡張する際の外径の連続的な変化を示すコンプライアンス曲線の傾きよりも大きく形成されてなる、拡張カテーテルである。 The dilatation catheter according to the present invention is a long shaft having flexibility that can be inserted into a living body lumen, and is fixed to a distal end portion of the shaft, and is used for supply and discharge of a pressurized medium via the shaft. And an expansion section composed of a first expansion body and a second expansion body configured to be capable of expansion deformation and contraction deformation, and the second expansion body is disposed so as to cover an outer surface of the first expansion body. And the first expansion body is made of a material having higher pressure resistance than the second expansion body, and the pressurizing medium. The slope of the compliance curve indicating the continuous change in the outer diameter of the first expansion body per unit increase amount of the internal pressure of the expansion portion accompanying the supply of the continuation of the outer diameter when the second expansion body expands The slope of the compliance curve Made is larger than a dilatation catheter.
 本発明に係る拡張カテーテルによれば、拡張部は、第1拡張体を覆う第2拡張体が備える柔軟性により耐擦過性が向上されたものとなり、第1拡張体が備える耐圧性により拡張性が向上されたものとなる。さらに、第1拡張体のコンプライアンス曲線の傾きが、第2拡張体のコンプライアンス曲線の傾きよりも大きく形成されているため、拡張部の内圧が増加した際における第1拡張体の拡張変形量は、第2拡張体の拡張径に応じて制限される。したがって、第1拡張体の肉厚および第2拡張体の肉厚を薄くすることにより拡張部が細径化して構成される場合においても、拡張部全体が病変部に対して作用させる拡張力を所望の大きさまで高めることが可能になる。よって、通過性および拡張性とともに耐擦過性の向上が図られた拡張部を備える拡張カテーテルを提供することが可能になる。 According to the dilatation catheter according to the present invention, the dilatation portion has improved scratch resistance due to the flexibility of the second dilation body covering the first dilation body, and the extensibility due to the pressure resistance of the first dilation body. Will be improved. Furthermore, since the slope of the compliance curve of the first expansion body is formed larger than the slope of the compliance curve of the second expansion body, the amount of expansion deformation of the first expansion body when the internal pressure of the expansion portion increases is It restrict | limits according to the expansion diameter of a 2nd expansion body. Therefore, even when the expanded portion is configured to have a reduced diameter by reducing the thickness of the first expanded body and the thickness of the second expanded body, the expansion force that causes the entire expanded portion to act on the lesioned portion. It becomes possible to increase to a desired size. Therefore, it is possible to provide an dilatation catheter including an dilation portion that is improved in scratch resistance as well as passability and expandability.
実施形態に係る拡張カテーテルを示す図であり、(A)は、拡張カテーテルの全体構成を簡略化して示す図、(B)は、拡張カテーテルの先端側を示す拡大断面図である。It is a figure which shows the dilatation catheter which concerns on embodiment, (A) is a figure which simplifies and shows the whole structure of an dilatation catheter, (B) is an expanded sectional view which shows the front end side of an dilatation catheter. 実施形態に係る拡張カテーテルが備える拡張部の構成を説明するための図であって、(A)は、収縮した状態における拡張部を拡大して示す部分断面図、(B)は、拡張した状態における拡張部を拡大して示す部分断面図である。It is a figure for demonstrating the structure of the expansion part with which the dilatation catheter which concerns on embodiment is equipped, Comprising: (A) is a fragmentary sectional view which expands and shows the expansion part in the contracted state, (B) is the expanded state It is a fragmentary sectional view which expands and shows the expansion part in FIG. 図2(A)に示す3A部分を拡大して示す部分断面図である。It is a fragmentary sectional view which expands and shows 3A part shown to FIG. 2 (A). 、拡張部、第1拡張体、および第2拡張体の外径の変化と拡張部の内圧の変化との関係を示す図である。It is a figure which shows the relationship between the change of the outer diameter of an expansion part, a 1st expansion body, and a 2nd expansion body, and the change of the internal pressure of an expansion part. 第2拡張体の変形例を示す図であって、(A)は、第2拡張体の一部を拡大して示す斜視図、(B)は、図5(A)に示す5A-5A線に沿う第2拡張体の軸直交断面図である。FIG. 9 is a diagram showing a modification of the second expansion body, where (A) is a perspective view showing a part of the second expansion body in an enlarged manner, and (B) is a line 5A-5A shown in FIG. 5 (A). It is an axial orthogonal cross section of the 2nd expansion body in alignment with.
 以下、各図面を参照して、本発明の実施の形態を説明する。なお、図面の寸法比率は、説明の都合上誇張されており、実際の比率とは異なる場合がある。 Hereinafter, embodiments of the present invention will be described with reference to the drawings. In addition, the dimension ratio of drawing is exaggerated on account of description, and may differ from an actual ratio.
 図1は、実施形態に係る拡張カテーテルの全体構成を示す図、図2、図3は、拡張カテーテルが備える拡張部(第1拡張体、第2拡張体)の説明に供する図、図4は、拡張部、第1拡張体、および第2拡張体の外径の変化と拡張部の内圧の変化との関係を示す図である。 FIG. 1 is a diagram illustrating an overall configuration of an dilatation catheter according to the embodiment, FIGS. 2 and 3 are diagrams for explaining dilation portions (first dilation body and second dilation body) included in the dilatation catheter, and FIG. It is a figure which shows the relationship between the change of the outer diameter of an expansion part, a 1st expansion body, and a 2nd expansion body, and the change of the internal pressure of an expansion part.
 図1(A)、図1(B)を参照して、本実施形態に係る拡張カテーテル100は、長尺のシャフト120を生体器官に挿通させ、シャフト120の先端側に配置された拡張部200を病変部(狭窄部)において拡張させることにより病変部を押し広げて治療するカテーテルデバイスとして構成している。ただし、拡張カテーテル100は、例えば、病変部を拡張した後、バルーン拡張型ステント(BX型ステント)を病変部に留置するために使用されるステント留置用のカテーテルデバイスとして構成することも可能である。 With reference to FIGS. 1 (A) and 1 (B), the dilatation catheter 100 according to the present embodiment has a long shaft 120 inserted through a living organ, and an dilation portion 200 disposed on the distal end side of the shaft 120. It is configured as a catheter device for expanding and treating the lesion by expanding the lesion at the lesion (stenosis). However, the dilatation catheter 100 can also be configured as a stent placement catheter device that is used to place a balloon-expandable stent (BX-type stent) in the lesion after the lesion is expanded, for example. .
 また、本実施形態に係る拡張カテーテル100は、冠動脈に形成された病変部を押し広げるために使用されるPTCA拡張用カテーテルとして構成しているが、例えば、他の血管、胆管、気管、食道、その他消化管、尿道、耳鼻内腔、その他の臓器等の生体器官内に形成された病変部(狭窄部)の治療および改善を目的として使用されるものとして構成することも可能である。 In addition, the dilatation catheter 100 according to the present embodiment is configured as a PTCA dilatation catheter used to push and spread a lesion formed in the coronary artery. For example, other blood vessels, bile ducts, trachea, esophagus, In addition, it can be configured to be used for the purpose of treatment and improvement of a lesion (stenosis) formed in a living organ such as the digestive tract, urethra, ear-nose lumen, and other organs.
 まず、拡張カテーテル100の全体構成について説明する。 First, the overall configuration of the dilatation catheter 100 will be described.
 図1(A)、図1(B)に示すように、拡張カテーテル100は、生体管腔内に挿入可能な可撓性を備える長尺状のシャフト120と、シャフト120の先端部に固定された第1拡張体210および第2拡張体220からなる拡張部200と、シャフト120の基端部側に配置されたハブ150と、を備えている。拡張カテーテル100の説明においては、拡張部200が設けられた側を先端側と称し、ハブ150が設けられた側を基端側と称し、シャフト120の延伸方向を軸方向と称する。 As shown in FIGS. 1A and 1B, the dilatation catheter 100 is fixed to a long shaft 120 having flexibility that can be inserted into a living body lumen, and a distal end portion of the shaft 120. In addition, an expansion portion 200 including a first expansion body 210 and a second expansion body 220 and a hub 150 disposed on the base end side of the shaft 120 are provided. In the description of the dilatation catheter 100, the side on which the dilation portion 200 is provided is referred to as the distal end side, the side on which the hub 150 is provided is referred to as the proximal end side, and the extending direction of the shaft 120 is referred to as the axial direction.
 拡張カテーテル100は、シャフト120の先端部側寄りにガイドワイヤ180が導出される開口部135が設けられた、いわゆるラピッドエクスチェンジタイプと呼ばれるものである。ただし、拡張カテーテル100は、ガイドワイヤルーメン131がシャフト120の先端から基端に亘って延在するように形成された、いわゆるオーバーザワイヤタイプと呼ばれるカテーテルデバイスとして構成することも可能である。 The dilatation catheter 100 is a so-called rapid exchange type in which an opening 135 through which the guide wire 180 is led out is provided near the distal end side of the shaft 120. However, the dilatation catheter 100 can also be configured as a so-called over-the-wire type catheter device in which the guide wire lumen 131 extends from the distal end of the shaft 120 to the proximal end.
 図1(B)に示すように、シャフト120は、ガイドワイヤ180が挿通されるガイドワイヤルーメン131が形成された内管(内管シャフト)130と、内管130との間に加圧媒体が流通可能な加圧媒体ルーメン141を形成する外管(外管シャフト)140とにより構成している。 As shown in FIG. 1B, the shaft 120 has a pressurized medium between the inner tube (inner tube shaft) 130 in which the guide wire lumen 131 into which the guide wire 180 is inserted and the inner tube 130. An outer tube (outer tube shaft) 140 that forms a flowable pressurized medium lumen 141 is formed.
 シャフト120は、内管130が外管140に内挿されて、内管130および外管140が同心状に位置合わせてして配置された二重管構造で構成している。 The shaft 120 has a double tube structure in which the inner tube 130 is inserted into the outer tube 140 and the inner tube 130 and the outer tube 140 are concentrically positioned.
 図1(B)に示すように、内管130の先端には、内管130と別部材で構成された先端チップ240を固定している。ガイドワイヤルーメン131は、先端チップ240の先端に形成された先端開口部243と内管130の基端に形成された基端開口部135の二つの開口部に連通するようにシャフト120内に延在している。 As shown in FIG. 1 (B), a tip tip 240 made of a member different from the inner tube 130 is fixed to the tip of the inner tube 130. The guide wire lumen 131 extends into the shaft 120 so as to communicate with two openings, a distal end opening 243 formed at the distal end of the distal end tip 240 and a proximal end opening 135 formed at the proximal end of the inner tube 130. Exist.
 内管130の先端に取り付けた先端チップ240は、拡張カテーテル100の先端が生体器官(血管の内壁等)に接触した際に、生体器官に損傷が生じるのを防止する機能を有している。先端チップ240は、例えば、内管130よりも柔軟な管状部材により構成することができる。また、先端チップ240は、生体管腔内への挿入性や生体管腔内における移動性を考慮して、図示するように先端側へ向けて外径が漸減するテーパー形状に形成することが可能である。ただし、先端チップ240の設置は適宜省略することも可能である。 The distal tip 240 attached to the distal end of the inner tube 130 has a function of preventing the living organ from being damaged when the distal end of the dilatation catheter 100 comes into contact with the living organ (such as the inner wall of the blood vessel). The distal tip 240 can be constituted by a tubular member that is more flexible than the inner tube 130, for example. Further, the distal tip 240 can be formed in a tapered shape in which the outer diameter gradually decreases toward the distal end side as illustrated in consideration of the insertion property into the biological lumen and the mobility in the biological lumen. It is. However, the installation of the tip tip 240 can be omitted as appropriate.
 内管130は、基端側が径方向外側へ湾曲した中空のチューブ材によって構成している。内管130の先端近傍および先端チップ240の基端近傍には、溶着等の公知の方法により拡張部200が備える第1拡張体210の先端部211を液密・気密に接合している(図2(B)を参照)。 The inner tube 130 is configured by a hollow tube material whose proximal end is curved radially outward. Near the distal end of the inner tube 130 and the proximal end of the distal tip 240, the distal end portion 211 of the first expansion body 210 provided in the expansion portion 200 is joined in a liquid-tight and air-tight manner by a known method such as welding (FIG. 2 (B)).
 内管130の基端近傍には、外管140の所定の位置に形成された接続用開口部145を液密・気密に接合している。ガイドワイヤ180は、内管130の先端に設けられた先端チップ240の先端開口部243および内管130の基端に設けられた基端開口部135のそれぞれを入口または出口として、ガイドワイヤルーメン131に挿通される。 In the vicinity of the proximal end of the inner tube 130, a connection opening 145 formed at a predetermined position of the outer tube 140 is joined in a liquid-tight and air-tight manner. The guide wire 180 has a guide wire lumen 131 with the distal end opening 243 of the distal end tip 240 provided at the distal end of the inner tube 130 and the proximal end opening 135 provided at the proximal end of the inner tube 130 as inlets or outlets, respectively. Is inserted.
 内管130を構成する材料としては、例えば、ポリエチレン、ポリプロピレン、エチレン-プロピレン共重合体、エチレン-酢酸ビニル共重合体等のポリオレフィン、軟質ポリ塩化ビニル等の熱可塑性樹脂、シリコーンゴム、ラテックスゴム等の各種ゴム類、ポリウレタンエラストマー、ポリアミドエラストマー、ポリエステルエラストマー等の各種エラストマー、ポリアミド、結晶性ポリエチレン、結晶性ポリプロピレン等の結晶性プラスチックを使用することができる。これらの材料中に、例えば、ヘパリン、プロスタグランジン、ウロキナーゼ、アルギニン誘導体等の抗血栓性物質を配合し、抗血栓性を有する材料とすることも可能である。 Examples of the material constituting the inner tube 130 include polyolefins such as polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, thermoplastic resins such as soft polyvinyl chloride, silicone rubber, latex rubber, etc. These various rubbers, various elastomers such as polyurethane elastomer, polyamide elastomer and polyester elastomer, and crystalline plastics such as polyamide, crystalline polyethylene and crystalline polypropylene can be used. In these materials, for example, an antithrombotic substance such as heparin, prostaglandin, urokinase, arginine derivative or the like can be blended to obtain a material having antithrombotic properties.
 外管140は、拡張部200の基端部(第1拡張体210の基端部213および第2拡張体220の基端部213)付近からハブ150まで延伸する中空状のチューブ材により構成している。外管140の先端近傍には、拡張部200が備える第1拡張体210の基端部213を溶着等の公知の方法により液密・気密に接合している(図2(B)を参照)。 The outer tube 140 is formed of a hollow tube material extending from the vicinity of the base end portion of the expansion portion 200 (the base end portion 213 of the first expansion body 210 and the base end portion 213 of the second expansion body 220) to the hub 150. ing. In the vicinity of the distal end of the outer tube 140, a base end portion 213 of the first expansion body 210 provided in the expansion portion 200 is joined in a liquid-tight and air-tight manner by a known method such as welding (see FIG. 2B). .
 外管140の構成材料としては、例えば、内管130と同様の材料を用いることが可能である。また、外管140において血液と接触する部分(例えば、外管140の外表面)に抗血栓性を有する物質をコーティングすることも可能である。 As a constituent material of the outer tube 140, for example, the same material as that of the inner tube 130 can be used. It is also possible to coat a substance having antithrombogenicity on a portion of the outer tube 140 that comes into contact with blood (for example, the outer surface of the outer tube 140).
 図1(A)に示すように、ハブ150は、加圧媒体を供給するためのインデフレーター等の供給装置(図示省略)と液密・気密に接続可能な接続部151を備えている。ハブ150の接続部151は、例えば、流体チューブ等が接続・分離可能に構成された公知のルアーテーパー等によって構成することができる。 As shown in FIG. 1A, the hub 150 includes a connecting portion 151 that can be connected in a liquid-tight and air-tight manner to a supply device (not shown) such as an indeflator for supplying a pressurized medium. The connecting portion 151 of the hub 150 can be configured by, for example, a known luer taper configured such that a fluid tube or the like can be connected / separated.
 拡張部200の拡張に使用される加圧媒体(例えば、生理食塩水、造影剤等)は、ハブ150の接続部151を介してシャフト120内へ流入させることができる。加圧媒体は、加圧媒体ルーメン141を経由して拡張部200の内部空間207へ供給される。拡張部200の内部空間207とは、拡張部200が備える第1拡張体210の内面と内管130の外面との間に区画形成される空間部のことである(図2(B)を参照)。 The pressurized medium (for example, physiological saline, contrast medium, etc.) used for the expansion of the expansion part 200 can be caused to flow into the shaft 120 via the connection part 151 of the hub 150. The pressurized medium is supplied to the internal space 207 of the expansion unit 200 via the pressurized medium lumen 141. The internal space 207 of the expansion part 200 is a space part that is defined between the inner surface of the first expansion body 210 provided in the expansion part 200 and the outer surface of the inner tube 130 (see FIG. 2B). ).
 次に、拡張カテーテル100が備える拡張部200について説明する。 Next, the expansion part 200 provided in the dilatation catheter 100 will be described.
 図2(A)、(B)に示すように、拡張部200は、当該拡張部200の内側(内管130寄り)に配置される第1拡張体210と、第1拡張体210の外表面を覆うように配置される第2拡張体220とにより構成している。すなわち、拡張部200は、内層をなす第1拡張体210と、外層をなす第2拡張体220とにより構成された2層構造を有している。 As shown in FIGS. 2A and 2B, the expansion part 200 includes a first expansion body 210 disposed inside the expansion part 200 (near the inner tube 130), and an outer surface of the first expansion body 210. And the second expansion body 220 arranged so as to cover. That is, the expansion part 200 has a two-layer structure including a first expansion body 210 forming an inner layer and a second expansion body 220 forming an outer layer.
 第1拡張体210および第2拡張体220のそれぞれは、拡張部200の内部空間207内への加圧媒体の流入および排出に伴い拡張変形および収縮変形可能に構成されている。拡張部200は、第1拡張体210および第2拡張体220が組み合わされることにより、全体として病変部等を押し広げる機能を有する部位、つまり従来公知のバルーンカテーテルにおけるバルーンと同様の機能を有する部位として構成されている。 Each of the first expansion body 210 and the second expansion body 220 is configured to be capable of expansion deformation and contraction deformation as the pressurized medium flows into and out of the internal space 207 of the expansion portion 200. The expanded portion 200 is a portion having a function of expanding the lesioned portion or the like as a whole by combining the first expanded body 210 and the second expanded body 220, that is, a portion having the same function as a balloon in a conventionally known balloon catheter. It is configured as.
 本実施形態に係る拡張カテーテル100においては、第1拡張体210および第2拡張体220のそれぞれに異なる物性を備えさせることにより、第1拡張体210および第2拡張体220のそれぞれに異なる機能を持たせている。具体的には、第1拡張体210は、主として、拡張部200が病変部を押し広げる際に付与する拡張力を高める役割を担っており、第2拡張体220は、主として、拡張部200の耐擦過性の向上、および、拡張時の拡張部200の外径(拡張変形量)を調整する役割を担っている。 In the dilatation catheter 100 according to the present embodiment, the first dilation body 210 and the second dilation body 220 have different functions by providing the first dilation body 210 and the second dilation body 220 with different physical properties. I have it. Specifically, the first expansion body 210 mainly plays a role of increasing the expansion force applied when the expansion section 200 spreads the lesioned area, and the second expansion body 220 mainly functions as the expansion section 200. It plays the role of improving the scratch resistance and adjusting the outer diameter (expansion deformation amount) of the expanded portion 200 during expansion.
 第1拡張体210は第2拡張体220よりも耐圧性の高い材料(高圧性を備える材料)で構成される。第1拡張体210の構成材料としては、例えば、ポリアミドやPETなどを使用することが可能である。なお、第1拡張体210の構成材料としては、好ましくはポリアミドである。 The first expansion body 210 is made of a material having a higher pressure resistance than the second expansion body 220 (a material having a high pressure property). As a constituent material of the first expansion body 210, for example, polyamide, PET, or the like can be used. The constituent material of the first expansion body 210 is preferably polyamide.
 上記ポリアミドとしては、例えば、ポリテトラメチレンアジパミド(ナイロン46)、ポリカプロラクタム(ナイロン6)、ポリヘキサメチレンアジパミド(ナイロン66)、ポリヘキサメチレンセバカミド(ナイロン610)、ポリヘキサメチレンドデカミド(ナイロン612)、ポリウンデカノラクタム(ナイロン11)、ポリドデカノラクタム(ナイロン12)などの単独重合体、カプロラクタム/ラウリルラクタム共重合体(ナイロン6/12)、カプロラクタム/アミノウンデカン酸共重合体(ナイロン6/11)、カプロラクタム/ω-アミノノナン酸共重合体(ナイロン6/9)、カプロラクタム/ヘキサメチレンジアンモニウムアジペート共重合体(ナイロン6/66)などの共重合体、アジピン酸とメタキシレンジアミンとの共重合体、またはヘキサメチレンジアミンとm,p-フタル酸との共重合体などの芳香族ポリアミドなどが挙げられる。 Examples of the polyamide include polytetramethylene adipamide (nylon 46), polycaprolactam (nylon 6), polyhexamethylene adipamide (nylon 66), polyhexamethylene sebacamide (nylon 610), polyhexamethylene Homopolymers such as dodecanamide (nylon 612), polyundecanolactam (nylon 11), polydodecanolactam (nylon 12), caprolactam / lauryl lactam copolymer (nylon 6/12), caprolactam / aminoundecanoic acid co Copolymers (nylon 6/11), caprolactam / ω-aminononanoic acid copolymer (nylon 6/9), caprolactam / hexamethylene diammonium adipate copolymer (nylon 6/66), adipic acid and Meta-xylene Copolymers of, or hexamethylene diamine and m, and aromatic polyamides such as a copolymer of p- phthalic acid.
 また、ナイロン6、ナイロン66、ナイロン11、ナイロン12などをハードセグメントとし、ポリアルキレングリコール、ポリエーテル、または脂肪族ポリエステルなどをソフトセグメントとするブロック共重合体であるポリアミドエラストマーも用いることが可能である。また、上記ポリアミドは、1種単独で使用してもよいし、2種以上を併用してもよい。 It is also possible to use a polyamide elastomer which is a block copolymer having nylon 6, nylon 66, nylon 11, nylon 12 or the like as a hard segment and polyalkylene glycol, polyether or aliphatic polyester as a soft segment. is there. Moreover, the said polyamide may be used individually by 1 type, and may use 2 or more types together.
 第2拡張体220は第1拡張体210よりも柔軟性の高い材料で構成される。第2拡張体220の構成材料としては、例えば、ポリエステルエラストマー、ポリアミドエラストマー、ポリオレフィン(例えば、ポリエチレン、ポリプロピレン)、ポリ塩化ビニル、フッ素樹脂、シリコン、ウレタン等の高分子材料又はこれらの混合物、或いは上記2種以上の高分子材料を使用することが可能である。なお、第2拡張体220の構成材料としては、ポリエステルエラストマー、ポリアミドエラストマー等のエラストマー材料が好ましく、ポリアミドエラストマーが特に好ましい。 The second expansion body 220 is made of a material that is more flexible than the first expansion body 210. As a constituent material of the second expansion body 220, for example, a polyester elastomer, a polyamide elastomer, a polyolefin (for example, polyethylene, polypropylene), a polymer material such as polyvinyl chloride, a fluororesin, silicon, urethane, or a mixture thereof, or the above Two or more polymer materials can be used. In addition, as a constituent material of the 2nd expansion body 220, elastomer materials, such as a polyester elastomer and a polyamide elastomer, are preferable, and a polyamide elastomer is especially preferable.
 また、本実施形態に係る拡張カテーテル100においては、第1拡張体210は、第2拡張体220よりもコンプライアンス曲線の傾きが大きく形成されている。図4を参照して、コンプライアンス曲線、およびその傾きについて説明する。 Further, in the dilatation catheter 100 according to the present embodiment, the first dilation body 210 is formed with a larger slope of the compliance curve than the second dilation body 220. With reference to FIG. 4, a compliance curve and its inclination will be described.
 図4には、拡張部200の内圧の変化と、第1拡張体210の外径の変化(図中の実線A)、第2拡張体220の外径の変化(図中の破線B)、および拡張部200の外径の変化(図中の二点鎖線C)との関係を例示的に示している。 In FIG. 4, the change of the internal pressure of the expansion part 200, the change of the outer diameter of the first expansion body 210 (solid line A in the figure), the change of the outer diameter of the second expansion body 220 (dashed line B in the figure), And the relationship with the change (two-dot chain line C in a figure) of the outer diameter of the expansion part 200 is shown in illustration.
 曲線Aは、拡張部200へ加圧媒体が供給されて、拡張部200の内圧が増加した際に、内圧の単位増加量あたりにおける第1拡張体210の外径の連続的な変化(拡張変形量)を示すコンプライアンス曲線(コンプライアンスカーブ)を示している。また、曲線Bは、拡張部200へ加圧媒体が供給されて、拡張部200の内圧が増加した際に、内圧の単位増加量あたりにおける第2拡張体220の外径の連続的な変化を示すコンプライアンス曲線を示している。 Curve A shows a continuous change in the outer diameter of the first expansion body 210 per unit increase amount of the internal pressure (expansion deformation) when the pressurized medium is supplied to the expansion section 200 and the internal pressure of the expansion section 200 increases. The compliance curve (compliance curve) showing the amount) is shown. Curve B shows a continuous change in the outer diameter of the second expansion body 220 per unit increase amount of the internal pressure when the pressurized medium is supplied to the expansion unit 200 and the internal pressure of the expansion unit 200 increases. The compliance curve shown is shown.
 コンプライアンス曲線の傾きの大小とは、同一の圧力が付加された際の拡張変形量の比率を示すものであり、「コンプライアンス曲線の傾きが大きい」方が、「コンプライアンス曲線の傾きが小さい」ものよりも、同一の圧力が付与された状態において、その拡張変形量が大きくなることを意味する。また、各拡張体210、220の物性を示すコンプライアンス値は、各拡張体210、220の外径の絶対値を、当該外径まで拡張させた際に拡張部200に付与された圧力(内圧)の絶対値で除算して得られる値を意味する。 The slope of the compliance curve is the ratio of the amount of expansion deformation when the same pressure is applied. The larger the slope of the compliance curve, the lower the slope of the compliance curve. This also means that the amount of expansion deformation increases in the state where the same pressure is applied. Further, the compliance value indicating the physical properties of each expansion body 210, 220 is the pressure (internal pressure) applied to the expansion portion 200 when the absolute value of the outer diameter of each expansion body 210, 220 is expanded to the outer diameter. The value obtained by dividing by the absolute value of.
 本実施形態においては、図4に示すように、第1拡張体210のコンプライアンス曲線Aの傾きは、拡張部200の内圧が所定の値Psに達した以降に、第2拡張体210のコンプライアンス曲線Bの傾きよりも大きくなるように設定している。一方、拡張部200の内圧が所定の値Psに達するまでは、第1拡張体210のコンプライアンス曲線Aの傾きと第2拡張体220の第2拡張体210のコンプライアンス曲線Bの傾きは、略同一となるように設定している。 In this embodiment, as shown in FIG. 4, the slope of the compliance curve A of the first expansion body 210 is the compliance curve of the second expansion body 210 after the internal pressure of the expansion section 200 reaches a predetermined value Ps. It is set to be larger than the slope of B. On the other hand, the inclination of the compliance curve A of the first expansion body 210 and the inclination of the compliance curve B of the second expansion body 210 of the second expansion body 220 are substantially the same until the internal pressure of the expansion portion 200 reaches a predetermined value Ps. It is set to become.
 上記の「所定の値Ps」は、例えば、拡張カテーテル100を使用した各種の手技を行うに当たり、拡張部200から病変部への拡張圧の付与が開始されるタイミングの圧力に設定することができ、例えば、1~20atm設定することが可能である。 The above-mentioned “predetermined value Ps” can be set to a pressure at a timing when the application of the expansion pressure from the expansion unit 200 to the lesioned part is started in performing various procedures using the expansion catheter 100, for example. For example, it is possible to set 1 to 20 atm.
 上述したように、各拡張体210、220のそれぞれが異なる物性を備える材料で構成されており、かつ、各拡張体210、220のコンプライアンス曲線の傾きの大小関係を規定しているため、拡張部200は、以下のような性能を備えたものとなる。 As described above, each of the expansion bodies 210 and 220 is made of a material having different physical properties, and defines the magnitude relationship between the slopes of the compliance curves of the expansion bodies 210 and 220. 200 has the following performance.
 図2(A)に示すよう、拡張部200を収縮させた状態(内管130の周囲に折り畳んだ状態)においては、第1拡張体210よりも柔軟性の高い第2拡張体220が径方向内方側(内管130側)へ押し潰れるように変形して、拡張部200全体が内管130に密着する。このため、収縮時の拡張部200の外径は細径化されたものとなり、病変部に対する通過性が向上したものとなる。 As shown in FIG. 2A, in a state where the expansion portion 200 is contracted (a state where the expansion portion 200 is folded around the inner tube 130), the second expansion body 220 having higher flexibility than the first expansion body 210 is in the radial direction. By deforming so as to be crushed toward the inner side (inner tube 130 side), the entire extended portion 200 is in close contact with the inner tube 130. For this reason, the outer diameter of the expanded portion 200 at the time of contraction is reduced, and the permeability to the lesioned portion is improved.
 また、外層をなす第2拡張体220が第1拡張体210を保護する柔軟な層として機能するため、拡張部200の耐擦過性が向上したものとなる。したがって、病変部が石灰化して完全閉塞に近い状態まで症状が進行している場合においても、病変部を通過させる際に拡張部200全体を好適に保護することができる。 In addition, since the second expansion body 220 forming the outer layer functions as a flexible layer that protects the first expansion body 210, the scratch resistance of the expansion portion 200 is improved. Therefore, even when the lesion is calcified and the symptom has progressed to a state close to complete occlusion, the entire expanded portion 200 can be suitably protected when passing through the lesion.
 拡張部200が病変部を通過した後に拡張部200を拡張変形させると、第1拡張体210および第2拡張体220は、図4に示すコンプライアンス曲線に従って拡張する。具体的には、拡張部200の内圧が所定の圧力Psに達するまでは、各々の拡張体210、220は、コンプライアンス曲線A、Bの傾きが略同一となるように拡張し、拡張部200の内圧が所定の圧力Psに達した以降は、第1拡張体210のコンプライアンス曲線Aの傾きが、第2拡張体220のコンプライアンス曲線Bの傾きよりも大きくなるように、各々の拡張体210、220が拡張する。 When the expansion part 200 is expanded and deformed after the expansion part 200 has passed through the lesion, the first expansion body 210 and the second expansion body 220 expand according to the compliance curve shown in FIG. Specifically, until the internal pressure of the expansion unit 200 reaches a predetermined pressure Ps, the expansion bodies 210 and 220 expand so that the slopes of the compliance curves A and B become substantially the same, After the internal pressure reaches the predetermined pressure Ps, the expansion bodies 210 and 220 are arranged such that the slope of the compliance curve A of the first expansion body 210 is larger than the slope of the compliance curve B of the second expansion body 220. Expands.
 拡張部200の内圧が所定の圧力Psに達した以降は、第1拡張体210の拡張変形が、当該第1拡張体210の外表面を覆う第2拡張体220の外径に応じて制限される。本実施形態においては、第1拡張体210および第2拡張体220が共に拡張し、第1拡張体210よりも柔軟に形成された第2拡張体220に引っ張り力(テンション)が付加されてある程度の伸びが両端部側に生じた後、第2拡張体220の伸びが限界に達することで、以降の第2拡張体220の拡張変形が抑制される。このタイミングで第1拡張体210の拡張変形にも制限が掛かり始める(図2(B)を参照)。 After the internal pressure of the expansion part 200 reaches the predetermined pressure Ps, the expansion deformation of the first expansion body 210 is limited according to the outer diameter of the second expansion body 220 that covers the outer surface of the first expansion body 210. The In the present embodiment, the first expansion body 210 and the second expansion body 220 are both expanded, and a tensile force (tension) is applied to the second expansion body 220 formed more flexibly than the first expansion body 210 to some extent. Then, the expansion of the second expansion body 220 reaches the limit, and the subsequent expansion deformation of the second expansion body 220 is suppressed. At this timing, the expansion deformation of the first expansion body 210 starts to be limited (see FIG. 2B).
 その結果、拡張部200全体の外径の連続的な変化を示すコンプライアンス曲線C(図中の二点鎖線)の傾きは、第1拡張体210のコンプライアンス曲線Aの傾きと第2拡張体220のコンプライアンス曲線Bの傾きの間の中間値に調整される。つまり、拡張部200の外径は、第1拡張体210の外径と第2拡張体220の外径の間の中間値で推移するように変化する。よって、病変部を拡張させる際に、内圧の増加に伴って拡張部200全体が際限なく拡張変形するのを抑えることができ、病変部に対して所望の拡張力を作用させることが可能になる。 As a result, the slope of the compliance curve C (two-dot chain line in the figure) indicating a continuous change in the outer diameter of the entire expanded portion 200 is the slope of the compliance curve A of the first expanded body 210 and that of the second expanded body 220. It is adjusted to an intermediate value between the slopes of the compliance curve B. That is, the outer diameter of the expansion part 200 changes so as to change at an intermediate value between the outer diameter of the first expansion body 210 and the outer diameter of the second expansion body 220. Therefore, when expanding the lesioned part, it is possible to prevent the entire expanded part 200 from expanding and deforming indefinitely as the internal pressure increases, and a desired expansion force can be applied to the lesioned part. .
 拡張部200の内圧が所定の圧力Psに達する前の段階においては、各々の拡張体210、220は、コンプライアンス曲線A、Bの傾きが略同一となるように拡張するため、第1拡張体210の拡張変形が第2拡張体220によって制限されることはない。したがって、病変部に対して拡張力の付与を開始する前の段階においては、拡張部200全体を速やかに拡張変形させることが可能になる。 In the stage before the internal pressure of the expansion part 200 reaches the predetermined pressure Ps, the expansion bodies 210 and 220 expand so that the slopes of the compliance curves A and B become substantially the same. The expansion deformation is not limited by the second expansion body 220. Therefore, before the start of applying the expansion force to the lesioned part, the entire expansion part 200 can be rapidly expanded and deformed.
 なお、第1拡張体210のコンプライアンス曲線の傾き、および第2拡張体220のコンプライアンス曲線の傾きを所望の値に設定する方法としては、例えば、第1拡張体210の構成材料および第2拡張体220の構成材料の材質による調整、各拡張体210、220を構成するチューブ状素材(パリソン)を成形する際の拡張倍率の調整(素材内における分子配向の調整)などにより行うことが可能である。 In addition, as a method of setting the inclination of the compliance curve of the first expansion body 210 and the inclination of the compliance curve of the second expansion body 220 to desired values, for example, the constituent material of the first expansion body 210 and the second expansion body It is possible to perform adjustment by adjusting the material of the constituent material 220, adjusting the expansion ratio (adjusting the molecular orientation in the material) when forming the tube-shaped material (parison) constituting each expansion body 210, 220, and the like. .
 次に、拡張部200およびシャフト120の各部について詳細に説明する。 Next, each part of the expansion part 200 and the shaft 120 will be described in detail.
 図3に示すように、例えば、拡張部200が拡張変形する前の状態(拡張部200が折り畳まれた状態)における第1拡張体210の肉厚(膜厚)d1は、第2拡張体220の肉厚(膜厚)d2よりも薄くなるように形成することが可能である。なお、図3は、図2(A)に示す破線部3Aで囲んだ部分を示す拡大断面図である。 As shown in FIG. 3, for example, the thickness (film thickness) d1 of the first expansion body 210 before the expansion portion 200 is expanded and deformed (the expansion portion 200 is folded) is the second expansion body 220. It can be formed to be thinner than the thickness (film thickness) d2. 3 is an enlarged cross-sectional view showing a portion surrounded by a broken line portion 3A shown in FIG.
 前述したように、拡張部200は、第1拡張体210の外表面が耐擦過性に優れる第2拡張体220により覆われている。このため、比較的大きな耐圧性を備える(耐擦過性が比較的小さい)第1拡張体210の肉厚d1を薄く形成した場合においても、拡張部200を病変部に通過させる際に第1拡張体210を保護することが可能となる。よって、第1拡張体210の肉厚d1は、第2拡張体220よりも薄く形成することができる。 As described above, in the expansion part 200, the outer surface of the first expansion body 210 is covered with the second expansion body 220 having excellent scratch resistance. For this reason, even when the thickness d1 of the first expansion body 210 having a relatively large pressure resistance (relatively low scratch resistance) is formed thin, the first expansion is performed when the expansion portion 200 is passed through the lesion. The body 210 can be protected. Therefore, the thickness d1 of the first expansion body 210 can be formed thinner than that of the second expansion body 220.
 また、第2拡張体220は、拡張部200に耐擦過性を付加するもの、つまり拡張部200の外部から付与される負荷等に起因して外傷等が発生するのを防止するためのものであるため、その肉厚d2を過剰に大きく設定する必要はない。したがって、本実施形態においては、第1拡張体210の肉厚d1と第2拡張体220の肉厚d2とを合計した拡張部200の肉厚d3は、従来公知の一般的なバルーンカテーテルのバルーンに比して小さく設計することが可能である。当然、拡張部200の肉厚d3が小さく設計される場合においても、所望の耐擦過性を維持することができる。なお、拡張部200の内部空間207は、第1拡張体210の外表面と第2拡張体220の内表面との間に形成される空間には連通していない。そのため、本発明に係る拡張部200は、第2拡張体220が拡張部200の外部から付与される負荷等に起因して外傷等が発生した場合あっても、第1拡張体210の拡張により拡張することができる。 Further, the second expansion body 220 is to add scratch resistance to the expansion portion 200, that is, to prevent the occurrence of trauma due to a load applied from the outside of the expansion portion 200. Therefore, it is not necessary to set the wall thickness d2 excessively large. Therefore, in this embodiment, the thickness d3 of the expansion portion 200, which is the sum of the thickness d1 of the first expansion body 210 and the thickness d2 of the second expansion body 220, is the balloon of a conventionally known general balloon catheter. It is possible to design smaller than the above. Of course, even when the wall thickness d3 of the extended portion 200 is designed to be small, desired scratch resistance can be maintained. In addition, the internal space 207 of the expansion part 200 does not communicate with the space formed between the outer surface of the first expansion body 210 and the inner surface of the second expansion body 220. For this reason, the expansion unit 200 according to the present invention allows the second expansion body 220 to expand due to the expansion of the first expansion body 210 even when a trauma or the like occurs due to a load applied from the outside of the expansion unit 200. Can be extended.
 拡張カテーテル100がPTCA拡張用カテーテルとして構成される場合(特に、完全閉塞に近い状態にある石灰化病変部を治療対象として使用されるものである場合)、第1拡張体210の肉厚d1は、例えば、1~8μmに形成することができ、第2拡張体220の肉厚d2は、例えば、2~9μmに形成することができ、第1拡張体210および第2拡張体220の合計の肉厚(拡張部200の肉厚)d3は、例えば、3~10μmに形成することができる。なお、第1拡張体210の肉厚d1は、第2拡張体220の肉厚d2よりも薄く構成されるのが好ましい。 When the dilatation catheter 100 is configured as a PTCA dilatation catheter (particularly, when a calcified lesion in a state close to complete occlusion is used as a treatment target), the wall thickness d1 of the first dilator 210 is: For example, the thickness d2 of the second expansion body 220 can be formed to be 2 to 9 μm, for example, and the total of the first expansion body 210 and the second expansion body 220 can be formed. The wall thickness (thickness of the extended portion 200) d3 can be formed to 3 to 10 μm, for example. The wall thickness d1 of the first expansion body 210 is preferably configured to be thinner than the wall thickness d2 of the second expansion body 220.
 また、拡張カテーテル100がステント留置用のカテーテルデバイスとして構成される場合、第1拡張体210の肉厚d1は、例えば、1~28μmに形成することができ、第2拡張体220の肉厚d2は、例えば、2~29μmに形成することができ、第1拡張体210および第2拡張体220の合計の肉厚(拡張部200の肉厚)d3は、例えば、3~30μmに形成することができる。なお、第1拡張体210の肉厚d1は、第2拡張体220の肉厚d2よりも薄く構成されるのが好ましい。 Further, when the dilatation catheter 100 is configured as a catheter device for stent placement, the thickness d1 of the first dilation body 210 can be formed, for example, to 1 to 28 μm, and the wall thickness d2 of the second dilation body 220. Can be formed to, for example, 2 to 29 μm, and the total thickness (thickness of the expanded portion 200) d3 of the first extension body 210 and the second extension body 220 is, for example, 3 to 30 μm. Can do. The wall thickness d1 of the first expansion body 210 is preferably configured to be thinner than the wall thickness d2 of the second expansion body 220.
 上記の第1拡張体210の肉厚d1、第2拡張体220の肉厚d2、および拡張部200の肉厚d3の寸法は一例であり、各部の肉厚がこれらの値に限定されることない。 The dimensions of the thickness d1 of the first expansion body 210, the thickness d2 of the second expansion body 220, and the thickness d3 of the expansion section 200 are examples, and the thickness of each section is limited to these values. Absent.
 図2(B)に示すように、拡張部200が備える第1拡張体210は、先端部211が内管130の先端部および先端チップ240に固定されており、基端部213が外管140の先端部に固定されている。先端部211の基端側には、基端側へ向けて外径が大きくなるように変化する先端側テーパー部211aが形成されており、基端部213の先端側には、先端側へ向けて外径が大きくなるように変化する基端側テーパー部213aが形成されている。先端側テーパー部211aと基端側テーパー部213aとの間には、略直線状に延在するストレート部215が形成されている。 As shown in FIG. 2B, in the first expansion body 210 provided in the expansion section 200, the distal end portion 211 is fixed to the distal end portion of the inner tube 130 and the distal end tip 240, and the proximal end portion 213 is the outer tube 140. It is fixed to the tip of the. A distal end side taper portion 211a is formed on the proximal end side of the distal end portion 211 so that the outer diameter increases toward the proximal end side. The distal end side of the proximal end portion 213 is directed toward the distal end side. Thus, a proximal side taper portion 213a that changes so as to increase the outer diameter is formed. A straight portion 215 extending in a substantially linear shape is formed between the distal end side tapered portion 211a and the proximal end side tapered portion 213a.
 図2(B)に示すように、拡張部200が備える第2拡張体220は、先端部221が第1拡張体210の先端部211の外表面に固定されており、基端部223が第1拡張体210の基端部213の外表面に固定されている。また、先端部221の基端側には、基端側へ向けて外径が大きくなるように変化する先端側テーパー部221aが形成されており、基端部223の先端側には、先端側へ向けて外径が大きくなるように変化する基端側テーパー部223aが形成されている。先端側テーパー部221aと基端側テーパー部223aとの間には、略直線状に延在するストレート部225が形成されている。 As shown in FIG. 2B, in the second expansion body 220 provided in the expansion portion 200, the distal end portion 221 is fixed to the outer surface of the distal end portion 211 of the first expansion body 210, and the base end portion 223 is the first expansion end. It is fixed to the outer surface of the base end portion 213 of the one expansion body 210. Further, a distal end side taper portion 221a that changes so that the outer diameter increases toward the proximal end side is formed on the proximal end side of the distal end portion 221, and the distal end side of the proximal end portion 223 has a distal end side. A proximal-side tapered portion 223a that changes so as to increase the outer diameter toward is formed. A straight portion 225 extending substantially linearly is formed between the distal end side tapered portion 221a and the proximal end side tapered portion 223a.
 図2(B)に示すように、第1拡張体210の先端面および第2拡張体220の先端面は、病変部への通過性を向上させるために先端側へ向けて先細るテーパー形状に形成することが可能である。ただし、各拡張体210、220の先端面の形状は図示したようなテーパー形状に限定されることはない。 As shown in FIG. 2B, the distal end surface of the first expansion body 210 and the distal end surface of the second expansion body 220 have a tapered shape that tapers toward the distal end side in order to improve the passage to the lesioned part. It is possible to form. However, the shape of the tip surface of each expansion body 210, 220 is not limited to the tapered shape as shown in the figure.
 なお、第2拡張体220は、第1拡張体210の外表面を覆っていれば図2(B)の形状に限定されず、先端部221が第1拡張体210の先端部211よりも先端側に配置されて、内管130の先端部および先端チップ240に固定されていてもよい。また、第2拡張体220の基端部223は、第1拡張体210の基端部213よりも基端側に配置されて、外管140に固定されていてもよい。 The second expansion body 220 is not limited to the shape of FIG. 2B as long as it covers the outer surface of the first expansion body 210, and the distal end portion 221 is more distal than the distal end portion 211 of the first expansion body 210. It may be disposed on the side and fixed to the distal end portion of the inner tube 130 and the distal end tip 240. Further, the base end portion 223 of the second expansion body 220 may be disposed on the base end side with respect to the base end portion 213 of the first expansion body 210 and may be fixed to the outer tube 140.
 拡張カテーテル100の製造時には、第1拡張体210を構成する略円筒状のチューブ状素材(パリソン)と第2拡張体220を構成する略円筒状のチューブ状素材(パリソン)が準備される。これらの各素材は、一般的なバルーンカテーテルに備えられるバルーンの製造において用いられるものと同様に、例えば、各拡張体210、220の構成材料を所定の成形型(バルーン成形金型等)を使用して成形することで得ることができる。シャフト120に対して第1拡張体210を固定し、さらに第1拡張体210の外表面を覆うように配置した第2拡張体220を第1拡張体210に対して固定することにより、シャフト120に拡張部200を設けることが可能である。 At the time of manufacturing the dilatation catheter 100, a substantially cylindrical tube-shaped material (parison) constituting the first expansion body 210 and a substantially cylindrical tube-shaped material (parison) constituting the second expansion body 220 are prepared. Each of these materials is the same as that used in the manufacture of a balloon provided in a general balloon catheter, for example, using a predetermined molding die (balloon molding die or the like) as the constituent material of each expansion body 210, 220. And can be obtained by molding. The first expansion body 210 is fixed to the shaft 120, and the second expansion body 220 disposed so as to cover the outer surface of the first expansion body 210 is fixed to the first expansion body 210, thereby the shaft 120. It is possible to provide the extension part 200 in the.
 拡張部200において、第1拡張体210のストレート部215と第2拡張体220のストレート部225とが軸方向において重なる部分は、病変部に対して拡張力を作用させる拡張有効部(加圧部)205を構成する。 In the expansion portion 200, the portion where the straight portion 215 of the first expansion body 210 and the straight portion 225 of the second expansion body 220 overlap in the axial direction is an effective expansion portion (pressurizing portion) that applies expansion force to the lesioned portion. ) 205 is configured.
 図2(B)に示すように、シャフト120が備える内管130には、シャフト120の軸方向において拡張部200の中心部P1(拡張有効部205の中心部)が投影される位置を示すX線造影マーカー160を設置している。また、X線造影マーカー160は、シャフト120の軸方向における両端部161、163のそれぞれを、先端側および基端側に向けて外径が漸減するテーパー形状に形成している。 As shown in FIG. 2B, the inner tube 130 included in the shaft 120 has a position X at which the central portion P1 of the expansion portion 200 (the central portion of the expansion effective portion 205) is projected in the axial direction of the shaft 120. A line contrast marker 160 is provided. Further, the X-ray contrast marker 160 has both end portions 161 and 163 in the axial direction of the shaft 120 each having a tapered shape in which the outer diameter gradually decreases toward the distal end side and the proximal end side.
 X線造影マーカー160を設けることにより、拡張カテーテル100を使用した手技を行う際に、X線画像上において拡張部200の中心部P1を容易に確認することが可能になるため、手技を迅速に行うことが可能になる。また、X線造影マーカー160の先端部161が先端側へ向けて外径が漸減するテーパー状に形成されており、かつ、X線造影マーカー160の基端部163が基端側へ向けて外径が漸減するテーパー状に形成されているため、病変部に拡張部200を通過させる際に、第1拡張体210とX線造影マーカー160との擦れから第1拡張体210を保護することが可能になる。 By providing the X-ray contrast marker 160, when performing a procedure using the dilatation catheter 100, it becomes possible to easily confirm the central portion P1 of the dilation portion 200 on the X-ray image, so that the procedure can be performed quickly. It becomes possible to do. Further, the distal end portion 161 of the X-ray contrast marker 160 is formed in a tapered shape whose outer diameter gradually decreases toward the distal end side, and the proximal end portion 163 of the X-ray contrast marker 160 is outwardly directed toward the proximal end side. Since the diameter gradually decreases, the first expansion body 210 can be protected from rubbing between the first expansion body 210 and the X-ray contrast marker 160 when the expansion section 200 is passed through the lesion. It becomes possible.
 本実施形態に係る拡張カテーテル100においては、第1拡張体210は耐擦過性が比較的小さな材料で構成され、かつ、肉厚が小さく形成されることがある。また、拡張部200の収縮時には比較的柔軟な第2拡張体220の収縮に伴って第1拡張体210が内管130にしっかりと密着した状態になる。このため、拡張部200を病変部に通過させる際に第1拡張体210がX線造影マーカー160の両端部161、163に引っ掛かる等して擦れが発生する可能性がある。そこで、X線造影マーカー160の両端部161、163を滑らかなテーパー形状に形成することにより、このような擦れからの保護を図ることを可能にしている。さらに、病変部へのX線造影マーカー160の通過性を向上させることもできる。 In the dilatation catheter 100 according to the present embodiment, the first dilator 210 may be made of a material having a relatively small scratch resistance and may be formed with a small thickness. In addition, when the expansion portion 200 contracts, the first expansion body 210 is in close contact with the inner tube 130 as the relatively flexible second expansion body 220 contracts. For this reason, when the expansion part 200 is passed through the lesioned part, the first expansion body 210 may be rubbed by being caught on both end parts 161 and 163 of the X-ray contrast marker 160. Therefore, by forming both end portions 161 and 163 of the X-ray contrast marker 160 in a smooth tapered shape, it is possible to protect against such rubbing. Furthermore, the passability of the X-ray contrast marker 160 to the lesioned part can be improved.
 X線造影マーカー160は、例えば、X線造影性を備えるリング状の部材の両端部をテーパー形状に加工したものを内管130に嵌装および固定させたり、X線造影性を備えるリング状の部材とテーパー部分を構成する別部材とを組み合わせて一体化させたものを内管130に嵌装および固定させたりすることで設けることが可能である。なお、X線造影マーカー160の構成材料としては、例えば、白金、金、銀、チタン、タングステン等の金属、またはこれらの合金等により構成されたものを使用することができる。 The X-ray contrast marker 160 is, for example, a ring-shaped member having X-ray contrast properties that is processed into a tapered shape by fitting and fixing the inner tube 130, or a ring-shaped member having X-ray contrast properties. It is possible to provide by combining and fixing the member and another member constituting the tapered portion into the inner tube 130 so as to be integrated. In addition, as a constituent material of the X-ray contrast marker 160, what was comprised with metals, such as platinum, gold | metal | money, silver, titanium, tungsten, these alloys, etc. can be used, for example.
 拡張部200が備える第2拡張体220の外表面には、親水性コート層(表面潤滑層)を形成している。第2拡張体220の外表面に親水性コート層を設けているため、拡張部200を生体管腔内で移動させる際や病変部に通過させる際に、第2拡張体220と各部との間の摩擦抵抗が低減する。前述したように、第2拡張体220は、拡張部200の耐擦過性を向上させるために、比較的柔軟な材料で構成されており、摩擦抵抗もその分大きくなり易い。第2拡張体220の外表面に親水性コート層を形成することにより、耐擦過性を維持しつつ、病変部に対する摩擦抵抗が小さくなるため、病変部への通過性もより一層向上したものとなる。 A hydrophilic coat layer (surface lubrication layer) is formed on the outer surface of the second extension body 220 provided in the extension portion 200. Since the hydrophilic coat layer is provided on the outer surface of the second expansion body 220, when the expansion section 200 is moved in the living body lumen or passed through the lesioned portion, the space between the second expansion body 220 and each section is determined. The frictional resistance is reduced. As described above, the second expansion body 220 is made of a relatively flexible material in order to improve the scratch resistance of the expansion portion 200, and the frictional resistance tends to increase accordingly. By forming a hydrophilic coat layer on the outer surface of the second expanded body 220, the frictional resistance to the lesioned part is reduced while maintaining the scratch resistance, and the passage to the lesioned part is further improved. Become.
 親水性コート層は、例えば、親水性コート層を構成する溶媒(親水性高分子を含む溶媒)を第2拡張体220の外表面に塗布した後に、第2拡張体220の外表面に親水性高分子を架橋させることで形成することができる。上記溶媒としては、例えば、DMF、クロロホルム、アセトン、THF、ジオキサン、ベンゼンなどを使用することができる。これらは1種単独で用いてもよいし、2種以上併用してもよい。また、架橋させる方法としては、例えば、加熱処理および/または電子線照射により行うことが可能である。 For example, the hydrophilic coat layer is formed by applying a solvent constituting the hydrophilic coat layer (a solvent containing a hydrophilic polymer) to the outer surface of the second extended body 220 and then applying hydrophilicity to the outer surface of the second extended body 220. It can be formed by crosslinking a polymer. As the solvent, for example, DMF, chloroform, acetone, THF, dioxane, benzene and the like can be used. These may be used alone or in combination of two or more. Moreover, as a method of bridge | crosslinking, it can carry out by heat processing and / or electron beam irradiation, for example.
 次に、拡張カテーテル100の製造手順について説明する。 Next, the manufacturing procedure of the dilatation catheter 100 will be described.
 まず、第1拡張体210を準備する(第1準備工程)。第1準備工程では、例えば、第1拡張体210を構成するチューブ状素材を購入して準備したり、成形型を使用してチューブ状素材を成形したりして第1拡張体210を得る。 First, the first expansion body 210 is prepared (first preparation step). In the first preparation step, for example, a tube-shaped material constituting the first expansion body 210 is purchased and prepared, or the tube-shaped material is molded using a molding die to obtain the first expansion body 210.
 次に、第2拡張体220を準備する(第2準備工程)。第2準備工程では、第1準備工程と同様に、例えば、第2拡張体220を構成するチューブ状素材を購入して準備したり、成形型を使用してチューブ状素材を成形したりして第2拡張体220を得る。なお、第1準備工程と第2準備工程は、順不同であり、工程順番を入れ替えてもよい。また、第1準備工程と第2準備工程を合わせて、準備工程と称する。 Next, the second expansion body 220 is prepared (second preparation step). In the second preparation step, as in the first preparation step, for example, the tube-shaped material constituting the second expansion body 220 is purchased and prepared, or the tube-shaped material is formed using a forming die. A second expansion body 220 is obtained. In addition, a 1st preparatory process and a 2nd preparatory process are random, and you may replace process order. The first preparation process and the second preparation process are collectively referred to as a preparation process.
 次に、第1拡張体210をシャフト120に固定してシャフト組立体を形成する(シャフト組立体形成工程)。シャフト120は、第1拡張体210を固定する作業を行うのに先立ち、内管130、外管140、ハブ150を組み付けた状態で予め準備しておくことが可能である。なお、シャフト組立体とは、第1拡張体210がシャフト120に固定された状態の仕掛品(中間品)を便宜的に称したものである。 Next, the first expansion body 210 is fixed to the shaft 120 to form a shaft assembly (shaft assembly forming step). The shaft 120 can be prepared in advance in a state where the inner tube 130, the outer tube 140, and the hub 150 are assembled prior to performing the work of fixing the first expansion body 210. The shaft assembly is a work product (intermediate product) in a state where the first expansion body 210 is fixed to the shaft 120 for convenience.
 シャフト120に対する第1拡張体210の固定は、溶着や融着等の公知の方法で行うことが可能である。 The first expansion body 210 can be fixed to the shaft 120 by a known method such as welding or fusion.
 次に、第2拡張体220の外表面に親水性高分子の溶媒を塗布する(塗布工程)。その後、第2拡張体220に対して加熱処理および/または電子線処理を施すことにより、親水性高分子を架橋させて親水性コート層を形成する(コート層形成工程)。なお、塗布工程及びコート層形成工程は、シャフト組立体形成工程の前に行ってもよい。 Next, a hydrophilic polymer solvent is applied to the outer surface of the second expansion body 220 (application process). Thereafter, the second expansion body 220 is subjected to heat treatment and / or electron beam treatment to crosslink the hydrophilic polymer to form a hydrophilic coat layer (coat layer forming step). In addition, you may perform an application | coating process and a coating layer formation process before a shaft assembly formation process.
 第2拡張体220の外表面に親水性コート層を形成した後、シャフト120に固定した第1拡張体210を覆うようにして第2拡張体220をシャフト組立体に対して固定する。第2拡張体220は、例えば、シャフト120に直接固定してもよいし、図2(B)に示すように第1拡張体210に固定してもよい。シャフト組立体に対する第2拡張体220の固定は、溶着や融着等の公知の方法で行うことが可能である。 After forming a hydrophilic coat layer on the outer surface of the second expansion body 220, the second expansion body 220 is fixed to the shaft assembly so as to cover the first expansion body 210 fixed to the shaft 120. For example, the second expansion body 220 may be directly fixed to the shaft 120, or may be fixed to the first expansion body 210 as shown in FIG. The second expansion body 220 can be fixed to the shaft assembly by a known method such as welding or fusion.
 一般的に、第1拡張体210のように耐圧性が比較的大きな材料で構成され、かつ、肉厚が薄く形成されたものに対して熱的な負荷を掛けて親水性コート層を形成すると、熱の影響を受けて第1拡張体210の素材自体に熱硬化等の変形が容易に生じ得る。このため、親水性高分子を架橋させて第1拡張体210の外表面に親水性コート層を強固に固着させることが難しくなる。これに対して、本実施形態に係る拡張カテーテル100の製造方法においては、熱的な負荷を掛けた際に第1拡張体210よりも変形が比較的生じ難い第2拡張体220の外表面に対して加熱処理や電子線処理を施して親水性高分子を架橋させている。このため、第2拡張体220の外表面に親水性コート層を強固に固着させることが可能になる。さらに、第1拡張体210と第2拡張体220とを固定させる前に、第2拡張体220に対して加熱処理や電子線処理を施すため、第1拡張体210に熱的な影響が及ぶのを防止することができ、親水性コート層の形成に伴って第1拡張体210に不要な変形等が生じるのを防止することが可能になる。 In general, when a hydrophilic coat layer is formed by applying a thermal load to a material having a relatively high pressure resistance such as the first expansion body 210 and having a thin wall thickness, Under the influence of heat, deformation such as thermosetting can easily occur in the material of the first expansion body 210 itself. For this reason, it becomes difficult to crosslink the hydrophilic polymer and firmly fix the hydrophilic coat layer to the outer surface of the first expansion body 210. On the other hand, in the method for manufacturing the dilatation catheter 100 according to the present embodiment, the outer surface of the second dilator 220 that is relatively less likely to be deformed than the first dilator 210 when a thermal load is applied. On the other hand, the hydrophilic polymer is crosslinked by heat treatment or electron beam treatment. For this reason, the hydrophilic coat layer can be firmly fixed to the outer surface of the second expansion body 220. Furthermore, before the first expansion body 210 and the second expansion body 220 are fixed, the second expansion body 220 is subjected to a heat treatment or an electron beam process, so that the first expansion body 210 is thermally affected. Therefore, it is possible to prevent the first expansion body 210 from being undesirably deformed with the formation of the hydrophilic coat layer.
 以上、本実施形態に係る拡張カテーテル100によれば、拡張部200は、第1拡張体210を覆う第2拡張体220が備える柔軟性により耐擦過性が向上されたものとなり、第1拡張体210が備える耐圧性により拡張性が向上されたものとなる。さらに、第1拡張体210のコンプライアンス曲線の傾きが、第2拡張体220のコンプライアンス曲線の傾きよりも大きく形成されているため、拡張部200の内圧が増加した際における第1拡張体210の拡張変形量は、第2拡張体220の拡張径に応じて制限される。したがって、第1拡張体210の肉厚および第2拡張体220の肉厚を薄くすることにより拡張部200が細径化して構成される場合においても、拡張部200全体が病変部に対して作用させる拡張力を所望の大きさまで高めることが可能になる。よって、通過性および拡張性とともに耐擦過性の向上が図られた拡張部200を備える拡張カテーテル100を提供することが可能になる。 As described above, according to the dilatation catheter 100 according to this embodiment, the dilation portion 200 has improved scratch resistance due to the flexibility of the second dilation body 220 that covers the first dilation body 210, and the first dilation body. The expandability is improved by the pressure resistance of 210. Furthermore, since the slope of the compliance curve of the first expansion body 210 is larger than the slope of the compliance curve of the second expansion body 220, the expansion of the first expansion body 210 when the internal pressure of the expansion portion 200 increases. The amount of deformation is limited according to the expansion diameter of the second expansion body 220. Therefore, even when the expanded portion 200 is configured to have a reduced diameter by reducing the thickness of the first expanded body 210 and the thickness of the second expanded body 220, the entire expanded portion 200 acts on the lesion. It is possible to increase the expansion force to a desired magnitude. Therefore, it is possible to provide the dilatation catheter 100 including the dilation portion 200 in which the scratch resistance is improved as well as the passability and the expansibility.
 また、拡張変形前における第1拡張体210の肉厚は、拡張変形前における第2拡張体220の肉厚よりも薄いため、第1拡張体210の肉厚を薄く形成することを通じて拡張部200全体の肉厚を薄く形成することができ、拡張部200をより一層細径化して構成することが可能になる。 In addition, since the thickness of the first expansion body 210 before the expansion deformation is thinner than the thickness of the second expansion body 220 before the expansion deformation, the expansion portion 200 is formed by forming the first expansion body 210 thin. The overall thickness can be reduced, and the expanded portion 200 can be configured with a further reduced diameter.
 また、第1拡張体210のコンプライアンス曲線の傾きは、加圧媒体の供給に伴って拡張部200の内圧が所定の値Psに達した以降に、第2拡張体210のコンプライアンス曲線の傾きよりも大きくなり、拡張部200の内圧が所定の値Psに達するまでは、第2拡張体220のコンプライアンス曲線の傾きと略同一であるため、拡張部200の内圧が所定の圧力Psに達する前の段階においては、第1拡張体210の拡張変形が第2拡張体220によって制限されることがなく、拡張部200全体を速やかに拡張変形させることが可能になる。 In addition, the slope of the compliance curve of the first expansion body 210 is greater than the slope of the compliance curve of the second expansion body 210 after the internal pressure of the expansion section 200 reaches a predetermined value Ps as the pressurized medium is supplied. Since the inclination of the compliance curve of the second expansion body 220 is substantially the same until the internal pressure of the expansion portion 200 reaches the predetermined value Ps, the stage before the internal pressure of the expansion portion 200 reaches the predetermined pressure Ps. In, the expansion deformation of the first expansion body 210 is not limited by the second expansion body 220, and the entire expansion portion 200 can be rapidly expanded and deformed.
 また、シャフト120(内管130)は、当該シャフト120の軸方向において拡張部200の中心部P1が投影される位置を示すX線造影マーカー160を有し、当該X線造影マーカー160は、シャフト120の軸方向における両端部161、163が、先端側および基端側に向けて外径が漸減するテーパー形状に形成されているため、病変部に拡張部200を通過させる際に、第1拡張体210とX線造影マーカー160との擦れから第1拡張体210を好適に保護することが可能になる。 Further, the shaft 120 (inner tube 130) has an X-ray contrast marker 160 that indicates a position at which the central portion P1 of the expansion part 200 is projected in the axial direction of the shaft 120. The X-ray contrast marker 160 is Since both end portions 161 and 163 in the axial direction of 120 are formed in a tapered shape whose outer diameter gradually decreases toward the distal end side and the proximal end side, the first expansion is performed when the expanded portion 200 is passed through the lesioned portion. It becomes possible to suitably protect the first expansion body 210 from rubbing between the body 210 and the X-ray contrast marker 160.
 また、シャフト120と、シャフト120の先端部に固定された拡張変形および収縮変形可能な拡張部200とを備え、拡張部200が備える第1拡張体210の外表面が第2拡張体220により覆われて構成された拡張カテーテル100の製造方法を提供することが可能になる。具体的には、生体管腔内に挿入可能な可撓性を備える長尺状のシャフト120と、シャフト120の先端部に固定され、シャフト120を介した加圧媒体の供給および排出に伴い拡張変形および収縮変形可能に構成された拡張部200と、を有する拡張カテーテル100の製造方法であって、第1拡張体210及び第1拡張体210よりも柔軟な材料で形成された第2拡張体220を準備する準備工程と、第1拡張体210をシャフト120に固定してシャフト組立体を形成するシャフト組立体形成工程と、シャフト120に固定した第1拡張体210を覆うようにして第2拡張体220をシャフト組立体に固定し、第1拡張体210及び第2拡張体220からなる拡張部200を形成する固定工程と、を含み、第1拡張体210は、第2拡張体220よりも耐圧性の高い材料で構成されており、かつ、加圧媒体の供給に伴う拡張部200の内圧の単位増加量あたりにおける第1拡張体210の外径の連続的な変化を示すコンプライアンス曲線の傾きが、第2拡張体220が拡張する際の外径の連続的な変化を示すコンプライアンス曲線の傾きよりも大きく形成されている拡張カテーテル100の製造方法である。 Further, the shaft 120 and an expansion portion 200 that can be expanded and contracted and fixed to the tip portion of the shaft 120 are provided. The outer surface of the first expansion body 210 included in the expansion portion 200 is covered by the second expansion body 220. It is possible to provide a method for manufacturing the dilatation catheter 100 configured as described above. Specifically, a long shaft 120 having flexibility that can be inserted into a living body lumen, and fixed to the distal end portion of the shaft 120, and expanded as a pressurized medium is supplied and discharged through the shaft 120. And a second expansion body formed of a material more flexible than the first expansion body 210 and the first expansion body 210. 220, a shaft assembly forming step of forming the shaft assembly by fixing the first expansion body 210 to the shaft 120, and a second extension so as to cover the first expansion body 210 fixed to the shaft 120. Fixing the expansion body 220 to the shaft assembly and forming an expansion portion 200 composed of the first expansion body 210 and the second expansion body 220. The first expansion body 210 includes a second expansion body. It is made of a material having higher pressure resistance than the body 220, and shows a continuous change in the outer diameter of the first expansion body 210 per unit increase amount of the internal pressure of the expansion section 200 accompanying supply of the pressurized medium. This is a method for manufacturing the dilatation catheter 100 in which the slope of the compliance curve is formed to be larger than the slope of the compliance curve indicating a continuous change in the outer diameter when the second dilator 220 is expanded.
 また、第2拡張体220の外表面に親水性コート層を強固に固着させることでき、かつ、親水性コート層の形成に伴って第1拡張体210に不要な変形等が生じるのを防止することができる拡張カテーテル100の製造方法を提供するが可能になる。 In addition, the hydrophilic coat layer can be firmly fixed to the outer surface of the second extension body 220, and unnecessary deformation or the like is prevented from occurring in the first extension body 210 due to the formation of the hydrophilic coat layer. It is possible to provide a method of manufacturing the dilatation catheter 100 that can be used.
 <改変例>
 次に、拡張カテーテル100に備えられる第2拡張体の改変例を説明する。
<Modification example>
Next, a modified example of the second expansion body provided in the dilatation catheter 100 will be described.
 図5(A)は、改変例に係る第2拡張体320の一部を示す拡大斜視図であり、図5(B)は、改変例に係る第2拡張体320の軸直交断面図(図5(A)の矢印5A-5A線に沿う断面図)である。 FIG. 5A is an enlarged perspective view showing a part of the second expanded body 320 according to the modified example, and FIG. 5B is an axial orthogonal cross-sectional view of the second expanded body 320 according to the modified example (FIG. 5). FIG. 5A is a cross-sectional view taken along line 5A-5A in FIG.
 第1拡張体210を覆うように配置される第2拡張体320は、例えば、本改変例において示すように、その外表面の周方向に沿って複数の凹凸部325が形成されたものを使用することが可能である。このように、外表面に凹凸部325が形成されていることにより、拡張部200を拡張させた際に第2拡張体320が石灰化された病変部に対して機械的な係止力を作用させて喰い込むようになる。つまり、拡張部200にスコアリング機能を付加することが可能になるため、病変部の拡張作用(治療効果)を高めることが可能になる。また、病変部を通過させる際に第2拡張体320の外表面と病変部とが接触する接触面積が小さくなるため、病変部への通過性をより一層向上させることも可能になる。 As the second expansion body 320 disposed so as to cover the first expansion body 210, for example, as shown in this modification, a structure in which a plurality of uneven portions 325 are formed along the circumferential direction of the outer surface is used. Is possible. As described above, since the uneven portion 325 is formed on the outer surface, when the expanded portion 200 is expanded, a mechanical locking force acts on the lesion portion where the second expanded body 320 is calcified. Let me eat it. That is, since it becomes possible to add a scoring function to the expansion part 200, it becomes possible to enhance the expansion action (therapeutic effect) of the lesioned part. In addition, since the contact area between the outer surface of the second expansion body 320 and the lesioned portion when passing through the lesioned portion is reduced, it is possible to further improve the passage through the lesioned portion.
 図示例においては、軸直交断面が6角形であるチューブ状の素材を第2拡張体320に使用しているが、第2拡張体320の外形形状や断面形状は、外表面の周方向に複数の凹凸部が形成されている限りにおいて特に限定されない。また、第2拡張体320には、第1拡張体210との固定時の作業性等を考慮して、図示するように第1拡張体210が挿通可能な内腔323が形成されたものを使用することが可能である。 In the illustrated example, a tube-shaped material having a hexagonal axial cross section is used for the second expansion body 320. However, there are a plurality of external shapes and cross-sectional shapes of the second expansion body 320 in the circumferential direction of the outer surface. As long as the concavo-convex portion is formed, there is no particular limitation. In addition, the second expansion body 320 is formed with a lumen 323 into which the first expansion body 210 can be inserted as shown in the drawing in consideration of workability at the time of fixing to the first expansion body 210 and the like. It is possible to use.
 第2拡張体320の材質、コンプライアンス曲線の傾き等は、前述した第1実施形態と同様に構成することが可能である。また、第2拡張体320の外表面には、前述した親水性コート層を設けることも可能である。 The material of the second expansion body 320, the slope of the compliance curve, and the like can be configured in the same manner as in the first embodiment described above. In addition, the above-described hydrophilic coat layer can be provided on the outer surface of the second expansion body 320.
 以上、実施形態および改変例を通じて本発明に係る拡張カテーテルおよびその製造方法を説明したが、本発明は実施形態および改変例において説明した構成のみに限定されることはなく、特許請求の範囲の記載に基づいて適宜変更することが可能である。 As described above, the dilatation catheter and the manufacturing method thereof according to the present invention have been described through the embodiment and the modification. However, the present invention is not limited to the configuration described in the embodiment and the modification, and the description of the claims It is possible to change appropriately based on the above.
 本出願は、2015年3月27日に出願された日本国特許出願第2015-067111号に基づいており、その開示内容は、参照により全体として引用されている。 This application is based on Japanese Patent Application No. 2015-067111 filed on Mar. 27, 2015, the disclosure of which is incorporated by reference in its entirety.
100 拡張カテーテル、
120 シャフト、
130 内管、
140 外管、
160 X線造影マーカー、
161 先端部、
163 基端部、
200 拡張部、
205 拡張有効部、
210 第1拡張体、
220 第2拡張体、
320 第2拡張体、
325 凹凸部、
d1 第1拡張体の肉厚、
d2 第2拡張体の肉厚、
d3 拡張部の肉厚、
P1 拡張部の中心部、
Ps 所定の値。
100 dilatation catheter,
120 shaft,
130 inner pipe,
140 outer tube,
160 X-ray contrast marker,
161 tip,
163 proximal end,
200 extensions,
205 Extended effective part,
210 first extension,
220 second extension,
320 second extension,
325 irregularities,
d1 The thickness of the first expansion body,
d2 The thickness of the second expansion body,
d3 wall thickness of the extension,
The center of the P1 extension,
Ps Predetermined value.

Claims (7)

  1.  生体管腔内に挿入可能な可撓性を備える長尺状のシャフトと、
     前記シャフトの先端部に固定され、前記シャフトを介した加圧媒体の供給および排出に伴い拡張変形および収縮変形可能に構成された第1拡張体および第2拡張体からなる拡張部と、を備え、
     前記第2拡張体は、前記第1拡張体の外表面を覆うように配置され、かつ、前記第1拡張体よりも柔軟な材料で構成されており、
     前記第1拡張体は、前記第2拡張体よりも耐圧性の高い材料で構成されており、かつ、前記加圧媒体の供給に伴う前記拡張部の内圧の単位増加量あたりにおける当該第1拡張体の外径の連続的な変化を示すコンプライアンス曲線の傾きが、前記第2拡張体が拡張する際の外径の連続的な変化を示すコンプライアンス曲線の傾きよりも大きく形成されてなる、拡張カテーテル。
    A long shaft having flexibility that can be inserted into a body lumen;
    An extension portion formed of a first extension body and a second extension body, which is fixed to a tip portion of the shaft and configured to be capable of expansion deformation and contraction deformation in accordance with supply and discharge of a pressurized medium through the shaft. ,
    The second expansion body is arranged to cover the outer surface of the first expansion body, and is made of a material that is more flexible than the first expansion body,
    The first expansion body is made of a material having a higher pressure resistance than the second expansion body, and the first expansion body per unit increase amount of the internal pressure of the expansion portion accompanying the supply of the pressure medium. A dilatation catheter in which a slope of a compliance curve showing a continuous change in the outer diameter of the body is formed larger than a slope of a compliance curve showing a continuous change in the outer diameter when the second dilator expands .
  2.  拡張変形前における前記第1拡張体の肉厚は、拡張変形前における前記第2拡張体の肉厚よりも薄い、請求項1に記載の拡張カテーテル。 2. The dilatation catheter according to claim 1, wherein a wall thickness of the first expansion body before expansion deformation is thinner than a wall thickness of the second expansion body before expansion deformation.
  3.  前記第1拡張体のコンプライアンス曲線の傾きは、前記加圧媒体の供給に伴って前記拡張部の内圧が所定の値に達した以降に、前記第2拡張体のコンプライアンス曲線の傾きよりも大きくなり、前記拡張部の内圧が前記所定の値に達するまでは、前記第2拡張体のコンプライアンス曲線の傾きと略同一である、請求項1または請求項2に記載の拡張カテーテル。 The slope of the compliance curve of the first expansion body becomes larger than the slope of the compliance curve of the second expansion body after the internal pressure of the expansion portion reaches a predetermined value as the pressure medium is supplied. 3. The dilatation catheter according to claim 1, wherein the internal pressure of the dilation portion is substantially the same as an inclination of a compliance curve of the second dilation body until the internal pressure of the dilation portion reaches the predetermined value.
  4.  前記シャフトは、当該シャフトの軸方向において前記拡張部の中心部が投影される位置を示すX線造影マーカーを有し、
     前記X線造影マーカーは、前記シャフトの軸方向における両端部が、先端側および基端側に向けて外径が漸減するテーパー形状に形成されている、請求項1~3のいずれか1項に記載の拡張カテーテル。
    The shaft has an X-ray contrast marker indicating a position where a central portion of the extension portion is projected in the axial direction of the shaft,
    The X-ray contrast marker according to any one of claims 1 to 3, wherein both end portions in the axial direction of the shaft are formed in a tapered shape in which an outer diameter gradually decreases toward a distal end side and a proximal end side. The dilatation catheter as described.
  5.  前記第2拡張体の外表面には、周方向に沿って複数の凹凸部が形成されている、請求項1~4のいずれか1項に記載の拡張カテーテル。 The dilatation catheter according to any one of claims 1 to 4, wherein a plurality of irregularities are formed along the circumferential direction on the outer surface of the second dilator.
  6.  生体管腔内に挿入可能な可撓性を備える長尺状のシャフトと、前記シャフトの先端部に固定され、前記シャフトを介した加圧媒体の供給および排出に伴い拡張変形および収縮変形可能に構成された拡張部と、を有する拡張カテーテルの製造方法であって、
     第1拡張体及び前記第1拡張体よりも柔軟な材料で形成された第2拡張体を準備する準備工程と、
     前記第1拡張体を前記シャフトに固定してシャフト組立体を形成するシャフト組立体形成工程と、
     前記シャフトに固定した前記第1拡張体を覆うようにして前記第2拡張体を前記シャフト組立体に固定し、前記第1拡張体及び前記第2拡張体からなる前記拡張部を形成する固定工程と、を含み、
     前記第1拡張体は、前記第2拡張体よりも耐圧性の高い材料で構成されており、かつ、前記加圧媒体の供給に伴う前記拡張部の内圧の単位増加量あたりにおける当該第1拡張体の外径の連続的な変化を示すコンプライアンス曲線の傾きが、前記第2拡張体が拡張する際の外径の連続的な変化を示すコンプライアンス曲線の傾きよりも大きく形成されている拡張カテーテルの製造方法。
    A long shaft having flexibility that can be inserted into a living body lumen, and fixed to the tip of the shaft, and can be expanded and contracted in accordance with supply and discharge of a pressurized medium through the shaft. A dilatation catheter manufacturing method comprising:
    Preparing a first expansion body and a second expansion body formed of a material more flexible than the first expansion body;
    A shaft assembly forming step of fixing the first expansion body to the shaft to form a shaft assembly;
    A fixing step of fixing the second extension body to the shaft assembly so as to cover the first extension body fixed to the shaft, and forming the extension portion composed of the first extension body and the second extension body. And including
    The first expansion body is made of a material having a higher pressure resistance than the second expansion body, and the first expansion body per unit increase amount of the internal pressure of the expansion portion accompanying the supply of the pressure medium. An expansion catheter having a slope of a compliance curve showing a continuous change in the outer diameter of the body is larger than a slope of the compliance curve showing a continuous change in the outer diameter when the second expansion body is expanded. Production method.
  7.  前記シャフト組立形成工程または前記固定工程の前に、
     前記第2拡張体の外表面に親水性高分子の溶媒を塗布する塗布工程と、
     前記第2拡張体に対して加熱処理および/または電子線照射を施すことにより、前記親水性高分子を架橋させて親水性コート層を形成するコート層形成工程と、を有する請求項6に記載の拡張カテーテルの製造方法。
    Before the shaft assembly forming process or the fixing process,
    An application step of applying a hydrophilic polymer solvent to the outer surface of the second expansion body;
    A coating layer forming step of forming a hydrophilic coating layer by crosslinking the hydrophilic polymer by subjecting the second expansion body to heat treatment and / or electron beam irradiation. Method for producing a dilatation catheter.
PCT/JP2016/059053 2015-03-27 2016-03-22 Dilation catheter and method for manufacturing dilation catheter WO2016158584A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017509836A JPWO2016158584A1 (en) 2015-03-27 2016-03-22 Dilatation catheter and dilatation catheter manufacturing method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-067111 2015-03-27
JP2015067111 2015-03-27

Publications (1)

Publication Number Publication Date
WO2016158584A1 true WO2016158584A1 (en) 2016-10-06

Family

ID=57005064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/059053 WO2016158584A1 (en) 2015-03-27 2016-03-22 Dilation catheter and method for manufacturing dilation catheter

Country Status (2)

Country Link
JP (1) JPWO2016158584A1 (en)
WO (1) WO2016158584A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217486A1 (en) 2017-05-23 2018-11-29 Cryterion Medical, Inc. Cryoballoon for intravascular catheter system

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447497A (en) * 1992-08-06 1995-09-05 Scimed Life Systems, Inc Balloon catheter having nonlinear compliance curve and method of using
JP2001513374A (en) * 1997-08-08 2001-09-04 サンスコープ インターナショナル インコーポレイテッド Balloon catheter and method of using the same
JP2002143316A (en) * 2000-11-15 2002-05-21 Kawasumi Lab Inc Catheter and balloon catheter
JP2004305768A (en) * 2004-07-22 2004-11-04 Terumo Corp Medical device with surface having lubricity when it is humid
JP2004534555A (en) * 2000-11-28 2004-11-18 サイメッド ライフ システムズ,インコーポレーテッド Medical device for delivering a bioactive substance to a lumen
JP2012005705A (en) * 2010-06-25 2012-01-12 Asahi Intecc Co Ltd Balloon catheter
JP2012066008A (en) * 2010-09-27 2012-04-05 Terumo Corp Multiple structure balloon and method for manufacturing the same
WO2013133183A1 (en) * 2012-03-09 2013-09-12 テルモ株式会社 Balloon catheter

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447497A (en) * 1992-08-06 1995-09-05 Scimed Life Systems, Inc Balloon catheter having nonlinear compliance curve and method of using
JP2001513374A (en) * 1997-08-08 2001-09-04 サンスコープ インターナショナル インコーポレイテッド Balloon catheter and method of using the same
JP2002143316A (en) * 2000-11-15 2002-05-21 Kawasumi Lab Inc Catheter and balloon catheter
JP2004534555A (en) * 2000-11-28 2004-11-18 サイメッド ライフ システムズ,インコーポレーテッド Medical device for delivering a bioactive substance to a lumen
JP2004305768A (en) * 2004-07-22 2004-11-04 Terumo Corp Medical device with surface having lubricity when it is humid
JP2012005705A (en) * 2010-06-25 2012-01-12 Asahi Intecc Co Ltd Balloon catheter
JP2012066008A (en) * 2010-09-27 2012-04-05 Terumo Corp Multiple structure balloon and method for manufacturing the same
WO2013133183A1 (en) * 2012-03-09 2013-09-12 テルモ株式会社 Balloon catheter

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217486A1 (en) 2017-05-23 2018-11-29 Cryterion Medical, Inc. Cryoballoon for intravascular catheter system
CN110944707A (en) * 2017-05-23 2020-03-31 科里泰瑞恩医疗有限公司 Cryogenic balloon for intravascular catheter systems
EP3630260A4 (en) * 2017-05-23 2021-02-17 Boston Scientific Scimed, Inc. Cryoballoon for intravascular catheter system

Also Published As

Publication number Publication date
JPWO2016158584A1 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
US11357892B2 (en) Multilayer medical balloon
US8940010B2 (en) Catheter with a polymide distal tip
US8043279B2 (en) Catheter and medical tube
JP4593280B2 (en) Extruded tubular member with discontinuous stripes
US7226472B2 (en) Catheter balloon with advantageous cone design
US6129707A (en) Intravascular catheter with expanded distal tip
EP2895226B1 (en) Method of manufacturing a soft tip balloon catheter
EP3484571B1 (en) High-pressure dilation catheter balloon
WO2006134638A1 (en) Balloon catheter
CN105007956A (en) Catheter shaft and method of forming same
US6878329B2 (en) Method of making a catheter balloon using a polyimide covered mandrel
EP3205365B1 (en) Medical elongated body and balloon catheter
WO2016158584A1 (en) Dilation catheter and method for manufacturing dilation catheter
WO2015146259A1 (en) Balloon catheter and method for manufacturing balloon
JP5026278B2 (en) Medical compound balloon
JP6080838B2 (en) Balloon catheter and stent delivery system
WO2023157533A1 (en) Balloon catheter
WO2023157535A1 (en) Balloon catheter
JP2018149082A (en) Medical long body
WO2023157534A1 (en) Balloon catheter
JP7148308B2 (en) balloon catheter
JP2019058331A (en) Balloon catheter
JP2022106410A (en) Balloon catheter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16772465

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017509836

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16772465

Country of ref document: EP

Kind code of ref document: A1